WO2022102624A1 - Curable composition and cured product thereof - Google Patents

Curable composition and cured product thereof Download PDF

Info

Publication number
WO2022102624A1
WO2022102624A1 PCT/JP2021/041220 JP2021041220W WO2022102624A1 WO 2022102624 A1 WO2022102624 A1 WO 2022102624A1 JP 2021041220 W JP2021041220 W JP 2021041220W WO 2022102624 A1 WO2022102624 A1 WO 2022102624A1
Authority
WO
WIPO (PCT)
Prior art keywords
curable composition
indicates
carbon atoms
component
formula
Prior art date
Application number
PCT/JP2021/041220
Other languages
French (fr)
Japanese (ja)
Inventor
彰治 森山
雄介 山本
和義 保坂
和輝 江口
Original Assignee
日産化学株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日産化学株式会社 filed Critical 日産化学株式会社
Priority to JP2022561944A priority Critical patent/JPWO2022102624A1/ja
Priority to KR1020237016463A priority patent/KR20230104893A/en
Priority to CN202180074682.9A priority patent/CN116391001A/en
Publication of WO2022102624A1 publication Critical patent/WO2022102624A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/38Polymerisation using regulators, e.g. chain terminating agents, e.g. telomerisation
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/46Polymerisation initiated by wave energy or particle radiation
    • C08F2/48Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • C08F2/50Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/12Esters of monohydric alcohols or phenols
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/26Esters containing oxygen in addition to the carboxy oxygen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/102Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/106Esters of polycondensation macromers
    • C08F222/1063Esters of polycondensation macromers of alcohol terminated polyethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/106Esters of polycondensation macromers
    • C08F222/1065Esters of polycondensation macromers of alcohol terminated (poly)urethanes, e.g. urethane(meth)acrylates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F230/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F230/02Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J4/00Adhesives based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; adhesives, based on monomers of macromolecular compounds of groups C09J183/00 - C09J183/16
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics

Definitions

  • the present invention relates to a curable composition and a cured product thereof.
  • the adherend to be adhered includes an organic base material such as a printed wiring board and a transparent polyimide film, and an inorganic base material such as glass, aluminum, ITO (Indium Tin Oxide), and SiN (Silicon Nitride). Therefore, the adhesive needs to be designed according to each target adherend.
  • organic base material such as a printed wiring board and a transparent polyimide film
  • inorganic base material such as glass, aluminum, ITO (Indium Tin Oxide), and SiN (Silicon Nitride). Therefore, the adhesive needs to be designed according to each target adherend.
  • the epoxy curing system includes a compound having an epoxy group, an epoxy resin, and a resin component including a curing catalyst in which a cationic catalyst is generated by heat or light.
  • the radical curing system is generally a resin component containing a compound having an acrylate group or the like that undergoes radical polymerization, a resin thereof, and a radical initiator that generates a radical by irradiation with heat or ultraviolet rays.
  • the film thickness of the adhesive layer also referred to as an adhesive layer
  • the film thickness of the curable composition it is necessary to reduce the film thickness of the curable composition to be applied to the substrate.
  • many of the conventional curable compositions using a compound having an epoxy group have a high viscosity, and when it is applied with a thin film thickness, repelling and coating unevenness are likely to occur.
  • the radicals are susceptible to oxygen inhibition, so that the curability of the adhesive layer is low. Further, since the curing shrinkage at the time of curing is larger than that using an epoxy group, strain and voids are generated at the interface between the base material and the adhesive layer, and the adhesive strength (also referred to as adhesion) to the base material is generated. There is a problem that the
  • the present inventor has completed the present invention having the following gist. That is, it is a curable composition containing the following components (A) and (B).
  • X 2 represents a linear alkylene group having 2 to 14 carbon atoms. However, the alkylene group may be substituted with at least one of the following (i) and (ii).
  • the curable composition of the present invention Since the curable composition of the present invention has a low viscosity, it can be applied to various coating methods and can be uniformly coated without uneven film thickness. Further, when the curable composition of the present invention is used as an adhesive for a display element or a semiconductor element, the curing shrinkage is small and the adhesiveness is high. It is possible to suppress the generation and obtain a highly reliable element.
  • the mechanism by which the curable composition having the above-mentioned excellent properties is obtained by the present invention is not necessarily clear, but it is presumed as follows. A radically curable polymerizable compound that reacts with a radical is used as the curable composition. Therefore, since the viscosity is lower than that of the compound having an epoxy group, the viscosity of the curable composition using the compound is low.
  • the structure of X4 in the above formula [ 1 ] in the specific compound is a long-chain alkyl group in which the Tg of the cured product is low. Therefore, the curable composition containing the specific compound is cured while maintaining its viscosity, so that the adhesion to the base material and the member is improved. Further, since the structure of X4 has a large exclusion volume between molecules, it is possible to reduce the curing shrinkage.
  • the curable composition of the present invention contains the following components (A) and (B).
  • another aspect of the present invention is represented by the above formula [1]. It is a compound.
  • the component (A) is a monofunctional radically polymerizable compound containing a compound represented by the above formula [1] (also referred to as a specific compound) as an essential component.
  • the monofunctional radically polymerizable compound is a compound having one functional group that reacts with a radical in the molecule.
  • X 1 , X 2 , X 3 and X 4 are as defined above, but the following are preferable.
  • X 1 preferably has a structure represented by the above formula [1-a], formula [1-b], formula [1-c] or formula [1-d].
  • X 2 preferably has a structure represented by the following formula [X1a].
  • M 1 and M 2 independently represent -CH 2 -CH 2- , -CH (CH 3 ) -CH 2- or -CH 2 -CH (CH 3 )-.
  • Z 1 indicates -O-, -CO-, -COO- or -OCO-.
  • N indicates an integer of 0 to 4.
  • * 1 indicates the bond position with X 1 and * 2 indicates the bond position with X 3.
  • X 3 is preferably -O-, -CO-, -COO- or -OCO-.
  • X4 is preferably a branched alkyl group having 12 to 40 carbon atoms from the viewpoint of lowering the Tg of the cured product and increasing the intramolecular exclusion volume.
  • the specific compound is more preferably a compound represented by the following formula [1a].
  • R 1 represents a hydrogen atom or a methyl group.
  • L 1 and L 2 are independently -CH 2 -CH 2- , -CH (CH 3 ) -CH 2- or -CH, respectively. 2 -CH (CH 3 )-indicates.
  • Y 1 indicates -O-, -CO-, -COO- or -OCO-.
  • N indicates an integer of 0 to 4.
  • N Y 1 and L 2 have the above definitions independently.
  • Y 2 indicates -COO- or -OCO-.
  • L 3 is a single bond or a linear or branched form having 1 to 4 carbon atoms.
  • R 2 and R 3 independently represent a linear or branched alkyl group having 4 to 18 carbon atoms, respectively.
  • R 4 is a hydrogen atom or a linear or branched alkyl group having 1 to 18 carbon atoms.
  • L 3 represents a group other than a single bond
  • the total number of carbon atoms of L 3 and R 2 to R 4 is 11 to 39
  • L 3 represents a single bond.
  • the total number of carbon atoms of R2 to R4 is 11 to 39.
  • Specific specific compounds include compounds represented by the following formulas [A1] to [A5], and it is preferable to use these.
  • the component (A) may contain a monofunctional radically polymerizable compound other than the specific compound.
  • Examples of the monofunctional radically polymerizable compound other than the specific compound include 2-ethylhexyl acrylate, 1-butylethyl acrylate, 2-butoxyethyl acrylate, 2-cyanoethyl acrylate, benzyl acrylate, cyclohexyl acrylate, and 2-hydroxypropyl acrylate, 2 -Ethoxyethyl acrylate, N, N-diethyl-2-aminoethyl acrylate, N, N-dimethyl-2-aminoethyl acrylate, dicyclopentanyl acrylate, dicyclopentenyl acrylate, glycidyl acrylate, tetrahydrofurfuryl acrylate, isobol Nyl acrylate, isodecyl acrylate, lauryl acrylate, 4-acryloyl morpholine, 2-phenoxyethyl acrylate, diethylene glycol acrylate phenyl ether, 2,
  • NK Ester A-LEN-10, AM-90G, AM-130G, AMP-20GY, A-SA, S-1800A, CB-1, M-90G, M-230G, PHE-1G examples thereof include S, SA (above, manufactured by Shin-Nakamura Chemical Industry Co., Ltd.), Aronix M-111, M-120, M-140 (above, manufactured by Toagosei Co., Ltd.) and the like.
  • monofunctional aromatic urethane acrylate or aliphatic urethane acrylate may be contained from the viewpoint of curability and curing shrinkage of the adhesive layer.
  • a compound having a thiol group in the molecule may be contained from the viewpoint of enhancing the adhesion between the adhesive layer and the substrate.
  • Specific examples thereof include 1-decanethiol, 1-dodecanethiol, 1-hexadecanethiol, 1-octanethiol, 1-octadecanethiol and the like.
  • the monofunctional radically polymerizable compound other than the above it is preferable to contain a compound having a phosphoric acid group in the molecule for the purpose of enhancing the adhesion between the adhesive layer and the substrate.
  • a compound having a phosphoric acid group in the molecule include Hosmer M, PE, PP (all manufactured by Unichemical Co., Ltd.), light acrylate P-1A (N), and light ester P-1M. (The above is manufactured by Kyoeisha Chemical Co., Ltd.).
  • the component (A) only a specific compound can be used, or two or more specific compounds can be mixed and used. It is also possible to mix and use one or more specific compounds and a monofunctional radically polymerizable compound other than one or more specific compounds.
  • the ratio of the specific compound to the monofunctional radically polymerizable compound other than the specific compound among the components (A) is preferably 10 parts by mass or more when the component (A) is 100 parts by mass.
  • a thermal radical initiator that generates radicals by heat and a photoradical initiator that generates radicals by ultraviolet rays can be used. These are appropriately selected depending on the curing step of the curable composition.
  • Thermal radical initiators that generate radicals by heat include ketone peroxide structures, peroxyketal structures, hydroperoxide structures, dialkyl peroxide structures, diacyl peroxide structures, peroxyester structures, peroxydicarbonate structures, or Examples thereof include compounds having an azo-based structure. If a thermal radical initiator that generates gas when radicals are generated may generate voids, the thermal radical initiators include ketone peroxide structure, peroxyketal structure, hydroperoxide structure, and dialkyl peroxide. Compounds having a structure, a diacyl peroxide structure, a peroxy ester structure or a peroxy dicarbonate structure are preferable.
  • diisobutyryl peroxide cumylperoxyneodecanoate
  • di-n-propylperoxydicarbonate diisopropylperoxydicarbonate
  • di-sec-butylperoxydicarbonate 1,1,3.
  • 3-Tetramethylbutyl peroxyneodecanate bis (4-tert-butylcyclohexyl) peroxydicarbonate, bis (2-ethylhexyl) peroxydicarbonate, tert-hexylperoxyneodecanoate, tert-butylper Oxyneodecanoate, tert-butylperoxyneoheptanoate, tert-hexylperoxypivalate, tert-butylperoxypivalate, bis (3,5,5-trimethylhexanoyl) peroxide, dilaurylper Oxide, 1,1,3,3-tetramethylbutylperoxy-2-ethylhexanoate, dissuccinic acid peroxide, 2,5-dimethyl-2,5-bis (2-ethylhexanoylperoxy) hexane, tert-Hexylperoxy-2-ethylhexan
  • parloyl IB park mill ND
  • parloyl NPP parloyl IPP
  • parloyl SBP parloyl SBP
  • perocta ND parloyl TCP
  • parloyl OPP parloyl OPP
  • perhexyl ND perbutyl ND
  • perbutyl NHP perhexyl PV
  • perbutyl PV perloyl 355, parloyl L.
  • bis (4-tert-butylcyclohexyl) peroxydicarbonate parloyl TCP / manufactured by Nichiyu Co., Ltd.
  • tert-butylperoxypivalate perbutyl PV / Nichiyu Co., Ltd.
  • 1,1,3,3-Tetramethylbutylperoxy-2-ethylhexanoate (PeroctaO / manufactured by Nichiyu Co., Ltd.), 1,1-bis (tert-hexylperoxy) cyclohexane (Perhexa HC /) (Nippon Oil Co., Ltd.), 2,5-dimethyl-2,5-di (benzoylperoxy) hexane (Perhexa 25Z / Nichiyu Co., Ltd.), tert-butyl peroxybenzoate (Perbutyl Z / Nichiyu Co., Ltd.) and 1 , 4-Bis (tert-butylperoxyisopropyl) benzene (Perbutyl P / manufactured by Nichiyu Co., Ltd.) is preferably used.
  • the ratio of the thermal radical initiator used is 0.01 to 10% by mass with respect to 100 parts by mass of all the radically polymerizable compounds including the component (A) from the viewpoint of storage stability and curability of the curable composition. It is preferably a radical. More preferred is 0.05 to 5 parts by mass. Further, these thermal radical initiators may be used alone or in combination of two or more, depending on the above-mentioned characteristics.
  • 1-hydroxycyclohexylphenyl ketone (Omnirad 184 / IGM Resins), 2-hydroxy-2-methyl-1-phenylpropan-1-one (Omnirad 1173 / IGM Resins) from the viewpoint of reactivity and wavelength selectivity.
  • the ratio of the photoradical initiator used is preferably 0.01 to 10 parts by mass with respect to 100 parts by mass of all the radically polymerizable compounds including the component (A) from the viewpoint of curability of the adhesive layer. .. More preferred is 0.05 to 5 parts by mass. Further, these photoradical initiators can be used alone or in combination of two or more depending on the wavelength of the light source used in the curing treatment and the curability of the adhesive layer.
  • a bifunctional or more radically polymerizable compound having two or more radical-reacting functional groups in the molecule as the component (C) (hereinafter, many). It is also preferable to use (referred to as a functional radically polymerizable compound).
  • polyfunctional radically polymerizable compounds include the following polyfunctional radically polymerizable compounds.
  • tricyclodecanedimethanol diacrylate tricyclodecanedimethanol dimethacrylate
  • polyethylene glycol # 200 diacrylate polyethylene glycol # 400 diacrylate
  • polyethylene glycol # 600 diacrylate from the viewpoint of film strength and curing shrinkage of the adhesive layer.
  • the component (C) preferably contains an aromatic urethane polyfunctional acrylate or an aliphatic urethane polyfunctional acrylate from the viewpoint of curability and curing shrinkage of the adhesive layer.
  • an aromatic urethane polyfunctional acrylate or an aliphatic urethane polyfunctional acrylate from the viewpoint of curability and curing shrinkage of the adhesive layer.
  • aliphatic urethane polyfunctional acrylates EBECRYL230, 4858, 8402, 8804, 8807, 4859, 8465, 8809 and 8811 (all manufactured by Dycel Ornex). ..
  • the component (C) preferably contains a polyfunctional radically polymerizable compound having a thiol group in the molecule from the viewpoint of enhancing the adhesion between the adhesive layer and the substrate.
  • a polyfunctional radically polymerizable compound having a thiol group in the molecule from the viewpoint of enhancing the adhesion between the adhesive layer and the substrate.
  • a polyfunctional radically polymerizable compound having a thiol group in the molecule from the viewpoint of enhancing the adhesion between the adhesive layer and the substrate.
  • a polyfunctional radically polymerizable compound having a thiol group in the molecule from the viewpoint of enhancing the adhesion between the adhesive layer and the substrate.
  • trimethylolpropanetris (3-mercaptopropionate)
  • tris-[(3-mercaptopropionyloxy) -ethyl] -isosyanurate pentaerythritol tetrakis (3-mercaptopropionat
  • the blending ratio of the polyfunctional radically polymerizable compound having a thiol group in the molecule is preferably 0.05 to 10 parts by mass, preferably 0.1 to 10 parts by mass, based on 100 parts by mass of the total of the components (A) and (C). 5 parts by mass is more preferable.
  • the compound having a thiol group acts as a chain transfer agent for radical polymerization.
  • the residue of the compound having one thiol group in the molecule is usually present at the end of the polymerized chain like the initiator.
  • the residue of the compound is polymerized as a result of not only acting as a chain transfer agent but also a growth reaction occurring from two or more thiol groups in the molecule. It exists in the middle of the chain.
  • a compound having 3 or more thiol groups in the molecule is used, a growth reaction occurs from the 3 or more thiol groups in the molecule, and as a result, the residue of the compound can also be a cross-linking point of the polymer chain. Therefore, in the present invention, the compound having two or more thiol groups in the molecule is included in the polyfunctional radically polymerizable compound.
  • a polyfunctional radically polymerizable compound having a phosphoric acid group in the molecule may be used for the purpose of enhancing the adhesion between the adhesive layer and the substrate.
  • Specific examples thereof include KAYAMER PM-2 or PM-21 (all manufactured by Nippon Kayaku Co., Ltd.).
  • the blending ratio of the polyfunctional radically polymerizable compound containing a phosphoric acid group in the molecule is preferably 0.01 to 3 parts by mass, preferably 0.05 with respect to 100 parts by mass of the total of the components (A) and (C). ⁇ 2 parts by mass is more preferable.
  • One or more of these polyfunctional radically polymerizable compounds can be used as the component (C).
  • the curable composition contains the component (A) and the component (B). At that time, the component (C) may be contained from the viewpoint of curability and film strength of the adhesive layer.
  • the blending ratio of the component (A) is preferably 10 to 99 parts by mass with respect to a total of 100 parts by mass of the component (A) and the component (C). Of these, 20 to 95 parts by mass is more preferable, and 40 to 90 parts by mass is even more preferable. Further, it is preferable that the component (C) is contained in an amount of 1 part by mass or more with respect to a total of 100 parts by mass of the component (A) and the component (C). Among them, 5 parts by mass or more is more preferable, and 10 parts by mass or more is more preferable.
  • the blending ratio of the component (C) is 90 parts by mass or less with respect to a total of 100 parts by mass of the component (A) and the component (C). It is preferably 80 parts by mass or less, more preferably 60 parts by mass or less.
  • the compounding ratio of the compound represented by the above formula [1] when the component (A) and the component (C) are contained is based on 100 parts by mass of the total of the component (A) and the component (C). 10 to 99 parts by mass is preferable. Of these, 20 to 95 parts by mass is more preferable, and 40 to 90 parts by mass is even more preferable.
  • the curable composition has a viscosity at 25 ° C. of 1 to 10000 mPa ⁇ s.
  • the viscosity at 25 ° C. is 1 to 500 mPa ⁇ s.
  • 1 to 300 mPa ⁇ s is more preferable, and 1 to 100 mPa ⁇ s is more preferable, from the viewpoint of maintaining dimensional control and reducing unevenness generated when the curable composition is applied or cured.
  • a method for preparing the curable composition a method of mixing the component (A), the component (B) and the component (C) together, or a method in which the component (A) and the component (C) are mixed in advance may be used.
  • B) A method of mixing the components can be mentioned.
  • the curable composition can be used as a varnish by adding a solvent.
  • a solvent As a result, the applicability to the base material can be improved and the processability can be improved.
  • the solvent at that time is not particularly limited as long as the component (A), the component (B) and the component (C) are uniformly dissolved, and known solvents can be used. Specifically, methanol, ethanol, isopropyl alcohol, acetone, toluene, tetrahydrofuran, hexane, ethyl acetate, 1-butanol, 2-methoxyethanol, 2-ethoxyethanol, cyclohexanone, propylene glycol monomethyl ether acetate, N-methyl-2.
  • the curable composition may contain an inorganic filler or an organic filler. Above all, it is preferable to use an inorganic filler from the viewpoint of increasing the heat resistance of the adhesive layer.
  • the inorganic filler include known ones, and examples thereof include aluminum hydroxide, magnesium hydroxide, boron nitride, crystalline silica, and amorphous silica. These can be used alone or in admixture of two or more.
  • a spacer for controlling the gap (also referred to as a gap) of the adhesive layer can be introduced into the curable composition.
  • the curable composition can be used, for example, as an adhesive.
  • the cured product of the present invention is obtained from the curable composition or adhesive of the present invention.
  • the cured product is obtained, for example, by a curing treatment of a curable composition described later.
  • the curable composition can be used as an adhesive for adhering a base material to a base material, attaching a member to the base material, or attaching a liquid crystal display element or an organic EL element to each other.
  • the bonding method include a step of applying the curable composition to the adhesive surface of one adherend (base material), and the other adherend (base material or member) to the adhesive surface of the adherend.
  • a method including a step of pasting the adhesive and a step of curing the curable composition can be mentioned.
  • the adhesive may be a solvent-free adhesive that does not substantially contain a solvent from the viewpoints of environment, safety and health.
  • substantially free means that the total amount of the curable composition is 100 parts by mass, and 0 to 0.5 parts by mass, preferably 0 to 0.2 parts by mass of the solvent is contained.
  • the curable composition of the present invention can also be used as a cured film such as an insulating film by applying the curable composition and curing it.
  • the methods for applying the curable composition to the substrate include spin coating method, slit coating method, roll coating method, inkjet method, screen printing method, bar coating method, flexographic printing method, gravure printing method, die coating method, and dispense.
  • spin coating method slit coating method, roll coating method, inkjet method, screen printing method, bar coating method, flexographic printing method, gravure printing method, die coating method, and dispense.
  • the law etc. can be mentioned. These are appropriately selected according to the type of the base material and the thickness of the target adhesive layer.
  • the curable composition of the present invention has a low viscosity and is therefore most suitable for application by inkjet.
  • the curing treatment of the curable composition is appropriately selected depending on the type of radical initiator.
  • a curable composition using a thermal radical initiator the following methods can be mentioned.
  • the curable composition is applied by the above method, and the base material is bonded to the base material, or the member is attached to the base material, and then heat treatment is performed.
  • the heating device used at that time include a hot plate, a heat circulation type oven, an IR (infrared) type oven, etc. Since curing inhibition occurs in the presence of oxygen, oxygen is removed in a nitrogen atmosphere or under vacuum. It is preferably in a state. Further, in the heat treatment, it is preferable to press the base materials against each other or between the base material and the member.
  • a curable composition using a photoradical initiator the following methods can be mentioned.
  • After applying the curable composition by the above method there is a method of laminating the other base material or pasting a member and irradiating with ultraviolet rays.
  • the layer of the cured composition after coating is irradiated with ultraviolet rays, and the other substrate is bonded.
  • Irradiation of ultraviolet rays in the temporary curing step is preferably performed in the atmosphere.
  • the main curing treatment include irradiation with ultraviolet rays or heat treatment.
  • the irradiation amount of ultraviolet rays and the temperature of the heat treatment are appropriately selected depending on the type of the substrate and the type of the radical initiator. It is preferable that the ultraviolet irradiation and the heat treatment are performed in a nitrogen atmosphere.
  • the oxygen concentration may be controlled to less than 100 mg / L.
  • the curing shrinkage rate can be determined by the method described in "Evaluation of curing shrinkage rate" described later.
  • Examples of the light source of the ultraviolet irradiation device used for irradiating ultraviolet rays include a metal halide lamp, a high-pressure mercury lamp, and an LED light source.
  • the wavelength of ultraviolet rays is preferably 250 to 450 nm. Of these, 310 to 400 nm is more preferable.
  • the illuminance of ultraviolet rays is preferably in the range of 1 to 50 mW / cm 2 from the viewpoint of improving productivity.
  • the irradiation amount of ultraviolet rays is preferably in the range of 50 mJ / cm 2 to 30,000 mJ / cm 2 from the viewpoint of sufficient curing.
  • oxides / nitrides for example, quartz, glass, silica, titania, alumina, sapphire, aluminosilicate glass, borosilicate glass, silicon nitride, SiON, ITO, IZO, IGZO, etc.
  • Plastics eg, polymethylmethacrylate, polyethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate, ABS, polycarbonate, polystyrene, epoxy, unsaturated polyester, melamine, diallyl phthalate, polyimide, urethane, nylon, polyethylene, polypropylene, cycloolefin polymer , Polyvinyl chloride, fluororesin (polytetrafluoroethylene resin, polychlorotrifluoroethylene resin, polyfluorovinylidene resin, polyvinylfluorovinyl resin, perfluoroalkoxyfluororesin,
  • fluororesin polytetraflu
  • glass, silica, alumina, aluminosilicate glass, borosilicate glass, silicon nitride, SiON, and ITO are preferable for the oxide / nitride for optical element applications.
  • the plastic is preferably polymethylmethacrylate, polyethylene terephthalate, polycarbonate, and polyimide. Aluminum, silver, copper, molybdenum, and alloys thereof are preferable as the metal.
  • optical element of the present invention is obtained by using the curable composition of the present invention. Further, the optical element of the present invention can be obtained by using the adhesive of the present invention.
  • the curable composition can also be suitably used as a sealing material for electronic devices.
  • the electronic device include an organic EL element, an organic thin-film solar cell, and a light emitting diode element.
  • a method for sealing the electronic device a known method can be used.
  • the curable composition can be applied onto a base material or a member by a spin coating method or an inkjet method, and then heat-treated or irradiated with ultraviolet rays to cure the electronic device. ..
  • the curable composition can also be used as an adhesive for attaching a plastic plate such as an acrylic plate or a transparent polyimide resin or a touch panel sensor to a liquid crystal display element, an organic EL display, a quantum dot display or the like. At that time, it can also be used when bonding display elements such as a liquid crystal display element, an organic EL display, and a quantum dot display.
  • Heptane (240 g) was added, and the saturated aqueous sodium hydrogen carbonate solution (240 g), dimethyl sulfoxide (240 g), and water (240 g) were separated and washed in this order to concentrate the organic layer.
  • the viscosity of the curable composition was measured, the adhesion was evaluated, and the curing shrinkage rate was evaluated by the following method.
  • a curable composition that was pressure-filtered with a membrane filter having a pore diameter of 1 ⁇ m was used.
  • Test cells were prepared by the following methods using the curable compositions (1) and (3) to (9) containing the thermal radical initiator, respectively.
  • Two glass substrates (length: 15 mm, width: 55 mm, thickness: 1.1 mm) washed with pure water, acetone and IPA (isopropyl alcohol) were prepared.
  • a 4 ⁇ m bead spacer was added in an amount of 0.5% by mass to the curable composition obtained above, and then spin-coated on one glass substrate (lower glass substrate 1) to form an uncured curable composition layer. (Hereinafter, also referred to as a glass substrate with an uncured curable composition layer) was obtained.
  • the other glass substrate (upper glass substrate 2) is brought into close contact with the glass substrate with the uncured curable composition layer so that the center points intersect in a direction orthogonal to the above-mentioned uncured curable composition layer, and a clip is used.
  • the two substrates were crimped to obtain a crimp cell.
  • the mixture was placed in a heat circulation type oven and heat-treated at 140 ° C. for 1 hour.
  • the substrate was deheated and the clip was removed to obtain a test cell for adhesion evaluation (including a cured product obtained from a curable composition using a thermal radical initiator).
  • the cured product obtained from the curable composition is sandwiched between the lower glass substrate 1 and the upper glass substrate 2 of the obtained test cell.
  • the adhesive layer region 3 is formed.
  • the other glass substrate (upper glass substrate 2) is brought into close contact with the glass substrate with the curable composition layer irradiated with ultraviolet rays so that the center points intersect in a direction orthogonal to the above-mentioned ultraviolet rays, and the two substrates are used with clips.
  • the mixture was placed in a heat circulation type oven and heat-treated at 140 ° C. for 1 hour. After the treatment, the substrate was deheated and the clip was removed to obtain a test cell for adhesion evaluation (including a cured product obtained from a curable composition using a photoradical initiator).
  • Examples 23 and 24 (curable compositions (20) and (21)), a glass substrate with an uncured curable composition layer prepared by the same method as described above was prepared, and the other glass was prepared.
  • the substrate (upper glass substrate 2) is brought into close contact with the glass substrate with the uncured curable composition layer so that the center points intersect in an orthogonal direction, and the two substrates are crimped using a clip to form a crimp cell. Obtained.
  • the crimping cell is irradiated with ultraviolet rays under the conditions that the wavelength of the light source of the ultraviolet light emitting diode is 365 nm, the illuminance of the ultraviolet rays is 6.6 mW / cm 2 , and the irradiation time is 220 seconds (total irradiation amount of 1452 mJ / cm 2 ).
  • a test cell for evaluation of adhesion (including a cured product obtained from a curable composition using a photoradical initiator) was obtained.
  • the adhesion was evaluated using the universal testing machine EZ-SX100N (Shimadzu Corporation) and the U-shaped jigs (upper jig 4 and lower jig 5) shown in FIGS. 2A and 2B. Specifically, the lower end portion 7 (the area in contact with the lower jig 5) of the upper glass substrate 2 of the test cell shown in FIG. 3 is in contact with the lower jig 5 of the testing machine. It was set so as to be in contact with the part 6 (the part in contact with the test cell).
  • the upper jig 4 of the testing machine is moved downward at a speed of 5 mm per second, and the upper jig 4 is brought into contact with the upper end 8 (the region in contact with the upper jig 4) of the lower glass substrate 1 of the test cell.
  • the test cell consisting of two substrates was vertically peeled off from the surface of the adhesive layer (cured product obtained from the curable composition).
  • the adhesion was calculated by dividing the maximum value of the force applied at this time by the area of the adhesive layer region 3. The higher the value, the better the adhesion.
  • the curing shrinkage was calculated by a density method using the density of the curable composition and the cured product thereof.
  • the cured product of the curable composition using the thermal radical initiator was prepared by heat-treating at 140 ° C. for 1 hour in a heat circulation type oven under a nitrogen atmosphere.
  • the cured product of the curable composition using the photoradical initiator uses an ultraviolet light emitting diode having a wavelength of a light source of 365 nm under a nitrogen atmosphere, an ultraviolet illuminance of 6.6 mW / cm 2 , and an irradiation time of 220 seconds. It was produced by performing the ultraviolet treatment (corresponding to a total irradiation amount of 1452 mJ / cm 2 ).
  • Curing shrinkage rate (%) ((d 1 / d 0 ) -1) ⁇ 100
  • d 0 is the density of the curable composition before curing
  • d 1 is the density of the curable composition after curing. The lower the value of the curing shrinkage rate, the smaller the curing shrinkage, that is, the better the curing shrinkage.
  • Table 2 shows the evaluation results of the curable composition using the thermal radical initiator
  • Table 3 shows the evaluation results of the curable composition using the photoradical initiator.
  • the curable composition containing the specific compound obtained in Examples 6 to 24 has a curable composition as compared with the curable composition of Comparative Example in which the specific compound is not used.
  • the viscosity of the compound was low, the adhesion when the cured film was produced was high, and the curing shrinkage was small.
  • the adhesion was higher than when it was not used.
  • Example 14 and Example 15 in the comparison under the same conditions.
  • a curable composition containing a compound having a specific structure By using a curable composition containing a compound having a specific structure, a radical curable composition having a low viscosity, a small curing shrinkage, and a high adhesion can be obtained. Therefore, the display element and the semiconductor element obtained by using the curable composition of the present invention as an adhesive are excellent in reliability.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

This curable composition contains the following components (A) and (B). Component (A): a monofunctional radical-polymerizable compound containing a compound represented by formula [1] Component (B): a radical initiator (In formula [1], X1 represents a structure selected from among formulae [1-a] to [1-g]. X2 represents a linear C2-14 alkylene group. The alkylene group may be subjected to specific substitution. X3 represents -O-, -CO-, -COO-, -OCO-, -CONH-, -NHCO-, or-NH-. X4 represents a linear or branched C12-40 alkyl group.) (TA represents a hydrogen atom or a benzene ring. * indicates a bond.)

Description

硬化性組成物及びその硬化物Curable composition and its cured product
 本発明は、硬化性組成物及びその硬化物に関する。 The present invention relates to a curable composition and a cured product thereof.
 表示素子や半導体素子では、素子内の様々な部材を付ける目的で、従来から種々の接着剤が用いられている。接着剤に求められる特性は、基材と部材との密着性と共に、その加工性や信頼性がある。 In display elements and semiconductor elements, various adhesives have been conventionally used for the purpose of attaching various members inside the element. The properties required for an adhesive are not only the adhesion between the base material and the member, but also its workability and reliability.
 また、接着する被着体には、プリント配線板や透明性ポリイミドフィルムなどの有機基材や、ガラス、アルミニウム、ITO(Indium Tin Oxide)、SiN(Silicon Nitride)などの無機基材がある。そのため、接着剤には、目的とする各被着体に応じた設計が必要となる。 Further, the adherend to be adhered includes an organic base material such as a printed wiring board and a transparent polyimide film, and an inorganic base material such as glass, aluminum, ITO (Indium Tin Oxide), and SiN (Silicon Nitride). Therefore, the adhesive needs to be designed according to each target adherend.
 これまで、表示素子や半導体素子の接着剤には、信頼性が高いエポキシ基を有する化合物を用いたエポキシ硬化系やラジカル重合性化合物を用いたラジカル硬化系の熱又は紫外線硬化性樹脂成分が用いられてきた(例えば、特許文献1及び特許文献2)。 So far, epoxy curable resin components using highly reliable epoxy group compounds and radical curable resin components using radically polymerizable compounds have been used as adhesives for display elements and semiconductor elements. (For example, Patent Document 1 and Patent Document 2).
 エポキシ硬化系としては、エポキシ基を有する化合物やエポキシ樹脂と、熱又は光でカチオン性の触媒が発生する硬化触媒を含む樹脂成分がある。一方、ラジカル硬化系は、ラジカル重合するアクリレート基などを有する化合物やその樹脂と、熱又は紫外線の照射でラジカルが発生するラジカル開始剤を含む樹脂成分が一般的である。 The epoxy curing system includes a compound having an epoxy group, an epoxy resin, and a resin component including a curing catalyst in which a cationic catalyst is generated by heat or light. On the other hand, the radical curing system is generally a resin component containing a compound having an acrylate group or the like that undergoes radical polymerization, a resin thereof, and a radical initiator that generates a radical by irradiation with heat or ultraviolet rays.
特開2010-229172号公報Japanese Unexamined Patent Publication No. 2010-229172 特開2002-203427号公報Japanese Unexamined Patent Publication No. 2002-203427
 光学素子の薄型化に伴い、それに用いられる接着剤層(接着層ともいう。)の膜厚を薄くすることが求められている。接着層の膜厚を薄くするためには、基材に塗布する硬化性組成物の膜厚を薄くする必要がある。ただし、これまでのエポキシ基を有する化合物を用いた硬化性組成物は、高粘度のものが多く、それを薄い膜厚で塗布した場合、ハジキや塗布ムラが発生しやすかった。 As the optical element becomes thinner, it is required to reduce the film thickness of the adhesive layer (also referred to as an adhesive layer) used for the optical element. In order to reduce the film thickness of the adhesive layer, it is necessary to reduce the film thickness of the curable composition to be applied to the substrate. However, many of the conventional curable compositions using a compound having an epoxy group have a high viscosity, and when it is applied with a thin film thickness, repelling and coating unevenness are likely to occur.
 また、ラジカル硬化型の組成物は、ラジカルが酸素阻害を受けやすいため、接着層の硬化性が低くなる。さらに、エポキシ基を用いたものに比べて、硬化時の硬化収縮が大きいため、基材と接着層との界面に歪や空隙が発生したり、基材に対する接着強度(密着性ともいう。)が低下する問題がある。 In addition, in the radical curable composition, the radicals are susceptible to oxygen inhibition, so that the curability of the adhesive layer is low. Further, since the curing shrinkage at the time of curing is larger than that using an epoxy group, strain and voids are generated at the interface between the base material and the adhesive layer, and the adhesive strength (also referred to as adhesion) to the base material is generated. There is a problem that the
 以上の点から、本発明は、硬化性組成物の粘度が低く、硬化収縮が小さく、且つ、密着性が高いラジカル硬化型の硬化性組成物を提供することを目的とする。 From the above points, it is an object of the present invention to provide a radical curable curable composition having a low viscosity, a small curing shrinkage, and a high adhesiveness.
 本発明者は、上記目的を達成するため鋭意研究を進めた結果、以下の要旨を有する本発明を完成するに至った。
 即ち、下記(A)成分及び(B)成分を含有する硬化性組成物である。
 (A)成分:下記式[1]で表される化合物(特定化合物ともいう)を含む単官能ラジカル重合性化合物
 (B)成分:ラジカル開始剤
Figure JPOXMLDOC01-appb-C000009
(式[1]中、Xは下記式[1-a]~式[1-g]から選ばれる構造を示す。
 Xは炭素数2~14の直鎖状のアルキレン基を示す。ただし、上記アルキレン基は、下記(i)及び(ii)の少なくともいずれかの置換が行われていてもよい。
  (i):上記アルキレン基のX又はXと隣り合わない任意の-CH-の、-O-、-CO-、-COO-、-OCO-、-CONH-、-NHCO-、-NH-、ベンゼン環又はシクロヘキサン環への置換
  (ii)上記アルキレン基の任意の-CH-の、-CH(CH)-への置換
 Xは-O-、-CO-、-COO-、-OCO-、-CONH-、-NHCO-又は-NH-を示す。
 Xは炭素数12~40の直鎖又は分岐状のアルキル基を示す。)
Figure JPOXMLDOC01-appb-C000010
(Tは水素原子又はベンゼン環を示す。*は結合手を示す。)
As a result of diligent research to achieve the above object, the present inventor has completed the present invention having the following gist.
That is, it is a curable composition containing the following components (A) and (B).
Component (A): Monofunctional radically polymerizable compound containing a compound represented by the following formula [1] (also referred to as a specific compound) Component (B): Radical initiator
Figure JPOXMLDOC01-appb-C000009
(In the formula [1], X 1 indicates a structure selected from the following formulas [1-a] to [1-g].
X 2 represents a linear alkylene group having 2 to 14 carbon atoms. However, the alkylene group may be substituted with at least one of the following (i) and (ii).
(I): Any -CH 2- , -O-, -CO-, -COO-, -OCO-, -CONH-, -NHCO-,-, which is not adjacent to X 1 or X 3 of the above alkylene group. Substitution with NH-, benzene ring or cyclohexane ring (ii) Substitution of any -CH 2- for the above alkylene group with -CH (CH 3 )-X 3 is -O-, -CO-, -COO- , -OCO-, -CONH-, -NHCO- or -NH-.
X4 represents a linear or branched alkyl group having 12 to 40 carbon atoms. )
Figure JPOXMLDOC01-appb-C000010
( TA indicates a hydrogen atom or a benzene ring. * Indicates a bond.)
 本発明の硬化性組成物は、粘度が低いことから、様々な塗布方法に対応でき、且つ、膜厚ムラが無い均一な塗布が可能となる。また、本発明の硬化性組成物を表示素子や半導体素子の接着剤に用いた場合、硬化収縮が小さく、且つ、密着性が高いことから、基材と接着層との間の歪や空隙の発生を抑制することができ、信頼性に優れた素子を得ることができる。
 本発明により何故に上記の優れた特性を有する硬化性組成物が得られるメカニズムは、必ずしも明らかではないが、ほぼ次のように推定される。
 硬化性組成物には、ラジカルで反応するラジカル硬化型の重合性化合物を用いている。そのため、エポキシ基を有する化合物に比べて粘度が低いため、それを用いた硬化性組成物の粘度は低くなる。
 また、特定化合物中の上記式[1]中のXの構造は、硬化物のTgが低くなる長鎖アルキル基である。そのため、特定化合物を含む硬化性組成物は、粘性を保ったまま硬化が進むため、基材及び部材との密着性が高くなる。更に、Xの構造は、分子間の排除体積が大きいため、硬化収縮の低減が可能となる。
Since the curable composition of the present invention has a low viscosity, it can be applied to various coating methods and can be uniformly coated without uneven film thickness. Further, when the curable composition of the present invention is used as an adhesive for a display element or a semiconductor element, the curing shrinkage is small and the adhesiveness is high. It is possible to suppress the generation and obtain a highly reliable element.
The mechanism by which the curable composition having the above-mentioned excellent properties is obtained by the present invention is not necessarily clear, but it is presumed as follows.
A radically curable polymerizable compound that reacts with a radical is used as the curable composition. Therefore, since the viscosity is lower than that of the compound having an epoxy group, the viscosity of the curable composition using the compound is low.
Further, the structure of X4 in the above formula [ 1 ] in the specific compound is a long-chain alkyl group in which the Tg of the cured product is low. Therefore, the curable composition containing the specific compound is cured while maintaining its viscosity, so that the adhesion to the base material and the member is improved. Further, since the structure of X4 has a large exclusion volume between molecules, it is possible to reduce the curing shrinkage.
密着性評価に用いるテストセルを上面から見た概略図である。It is the schematic which looked at the test cell used for the adhesion evaluation from the top surface. 密着性評価に用いるテストセルを側面から見た概略図である。It is the schematic which looked at the test cell used for the adhesion evaluation from the side. 密着性評価に用いるU字型の上部治具の概略図である。It is a schematic diagram of the U-shaped upper jig used for the adhesion evaluation. 密着性評価に用いるU字型の下部治具の概略図である。It is a schematic diagram of the U-shaped lower jig used for the adhesion evaluation. 密着性評価の際のテストセルとU字型治具が接触する領域を説明した、テストセルを上面から見た概略図である。It is the schematic which looked at the test cell from the top view explaining the area where the test cell and a U-shaped jig come into contact at the time of adhesion evaluation.
 以下、本発明について具体的に説明する。
 本発明の硬化性組成物は、下記(A)成分及び(B)成分を含有する。
 (A)成分:上記式[1]で表される化合物を含む単官能ラジカル重合性化合物
 (B)成分:ラジカル開始剤
 また、本発明の他の一態様は、上記式[1]で表される化合物である。
Hereinafter, the present invention will be specifically described.
The curable composition of the present invention contains the following components (A) and (B).
(A) Component: Monofunctional radically polymerizable compound containing the compound represented by the above formula [1] (B) Component: Radical initiator Further, another aspect of the present invention is represented by the above formula [1]. It is a compound.
<(A)成分>
 (A)成分は、上記式[1]で表される化合物(特定化合物ともいう)を必須成分として含む、単官能ラジカル重合性化合物である。ここで、単官能ラジカル重合性化合物とは、ラジカルで反応する官能基を分子内に1つ有する化合物である。
 式[1]中、X、X、X及びXは、上記に定義した通りであるが、なかでもそれぞれ、下記のものが好ましい。
 Xは、ラジカル反応の反応性を高める観点から、上記式[1-a]、式[1-b]、式[1-c]又は式[1-d]で表される構造が好ましい。
 Xは下記式[X1a]で表される構造が好ましい。
Figure JPOXMLDOC01-appb-C000011
(式[X1a]中、M及びMはそれぞれ独立して、-CH-CH-、-CH(CH)-CH-又は-CH-CH(CH)-を示す。Zは-O-、-CO-、-COO-又は-OCO-を示す。nは0~4の整数を示す。nが2以上の整数の場合、n個のZ及びMはそれぞれ独立して上記定義を有する。*1はXとの結合位置を示し、*2はXとの結合位置を示す。)
<Ingredient (A)>
The component (A) is a monofunctional radically polymerizable compound containing a compound represented by the above formula [1] (also referred to as a specific compound) as an essential component. Here, the monofunctional radically polymerizable compound is a compound having one functional group that reacts with a radical in the molecule.
In the formula [1], X 1 , X 2 , X 3 and X 4 are as defined above, but the following are preferable.
From the viewpoint of enhancing the reactivity of the radical reaction, X 1 preferably has a structure represented by the above formula [1-a], formula [1-b], formula [1-c] or formula [1-d].
X 2 preferably has a structure represented by the following formula [X1a].
Figure JPOXMLDOC01-appb-C000011
(In the formula [X1a], M 1 and M 2 independently represent -CH 2 -CH 2- , -CH (CH 3 ) -CH 2- or -CH 2 -CH (CH 3 )-. Z 1 indicates -O-, -CO-, -COO- or -OCO-. N indicates an integer of 0 to 4. When n is an integer of 2 or more, n Z 1 and M 2 are respectively. It has the above definition independently. * 1 indicates the bond position with X 1 and * 2 indicates the bond position with X 3. )
 Xは-O-、-CO-、-COO-又は-OCO-が好ましい。
 Xは、硬化物のTgを低くし、且つ、分子間の排除体積を大きくする観点から、炭素数12~40の分岐状のアルキル基が好ましい。
X 3 is preferably -O-, -CO-, -COO- or -OCO-.
X4 is preferably a branched alkyl group having 12 to 40 carbon atoms from the viewpoint of lowering the Tg of the cured product and increasing the intramolecular exclusion volume.
 このなかでも、特定化合物は、下記式[1a]で表される化合物がさらに好ましい。
Figure JPOXMLDOC01-appb-C000012
(式[1a]中、Rは水素原子又はメチル基を示す。L及びLはそれぞれ独立して、-CH-CH-、-CH(CH)-CH-又は-CH-CH(CH)-を示す。Yは-O-、-CO-、-COO-又は-OCO-を示す。nは0~4の整数を示す。nが2以上の整数の場合、n個のY及びLはそれぞれ独立して上記定義を有する。Yは-COO-又は-OCO-を示す。Lは単結合、又は炭素数1~4の直鎖或いは分岐状のアルキレン基を示す。R及びRはそれぞれ独立して炭素数4~18の直鎖或いは分岐状のアルキル基を示す。Rは水素原子、又は炭素数1~18の直鎖或いは分岐状のアルキル基を示す。但し、Lが単結合以外の基を表す場合、L、及びR~Rの炭素数の合計は11~39であり、Lが単結合を表す場合、R~Rの炭素数の合計は11~39である。)
Among these, the specific compound is more preferably a compound represented by the following formula [1a].
Figure JPOXMLDOC01-appb-C000012
(In the formula [1a], R 1 represents a hydrogen atom or a methyl group. L 1 and L 2 are independently -CH 2 -CH 2- , -CH (CH 3 ) -CH 2- or -CH, respectively. 2 -CH (CH 3 )-indicates. Y 1 indicates -O-, -CO-, -COO- or -OCO-. N indicates an integer of 0 to 4. When n is an integer of 2 or more. , N Y 1 and L 2 have the above definitions independently. Y 2 indicates -COO- or -OCO-. L 3 is a single bond or a linear or branched form having 1 to 4 carbon atoms. R 2 and R 3 independently represent a linear or branched alkyl group having 4 to 18 carbon atoms, respectively. R 4 is a hydrogen atom or a linear or branched alkyl group having 1 to 18 carbon atoms. When L 3 represents a group other than a single bond, the total number of carbon atoms of L 3 and R 2 to R 4 is 11 to 39, and L 3 represents a single bond. , The total number of carbon atoms of R2 to R4 is 11 to 39.)
 具体的な特定化合物としては、下記式[A1]~式[A5]で表される化合物が挙げられ、これらを用いることが好ましい。
Figure JPOXMLDOC01-appb-C000013
Specific specific compounds include compounds represented by the following formulas [A1] to [A5], and it is preferable to use these.
Figure JPOXMLDOC01-appb-C000013
 また、硬化性組成物の液物性や硬化物の膜物性を調整する点から、(A)成分は、特定化合物以外の単官能ラジカル重合性化合物を含んでいても良い。 Further, from the viewpoint of adjusting the liquid properties of the curable composition and the film properties of the cured product, the component (A) may contain a monofunctional radically polymerizable compound other than the specific compound.
 特定化合物以外の単官能ラジカル重合性化合物としては、例えば、2-エチルヘキシルアクリレート、1-ブチルエチルアクリレート、2-ブトキシエチルアクリレート、2-シアノエチルアクリレート、ベンジルアクリレート、シクロヘキシルアクリレート、2-ヒドロキシプロピルアクリレート、2-エトキシエチルアクリレート、N,N-ジエチル-2-アミノエチルアクリレート、N,N-ジメチル-2-アミノエチルアクリレート、ジシクロペンタニルアクリレート、ジシクロペンテニルアクリレート、グリシジルアクリレート、テトラヒドロフルフリルアクリレート、イソボルニルアクリレート、イソデシルアクリレート、ラウリルアクリレート、4-アクリロイルモルホリン、2-フェノキシエチルアクリレート、ジエチレングリコールアクリレートフェニルエーテル、2,2,2-トリフルオロエチルアクリレート、2,2,3,3,3-ペンタフルオロプロピルアクリレート、2,2,3,3-テトラフルオロプロピルアクリレート、2,2,3,4,4,4-ヘキサフルオロブチルアクリレート、2-エチルヘキシルメタクリレート、1-ブチルエチルメタクリレート、2-ブトキシエチルメタクリレート、2-シアノエチルメタクリレート、ベンジルメタクリレート、シクロヘキシルメタクリレート、2-ヒドロキシプロピルメタクリレート、2-エトキシエチルアクリレート、N,N-ジエチル-2-アミノエチルメタクリレート、N,N-ジメチル-2-アミノエチルメタクリレート、ジシクロペンタニルメタクリレート、ジシクロペンテニルメタクリレート、グリシジルメタクリレート、テトラヒドロフルフリルメタクリレート、イソボルニルメタクリレート、イソデシルメタクリレート、ラウリルメタクリレート、4-メタクリロイルモルホリン、2-フェノキシエチルメタクリレート、ジエチレングリコールメタクリレートフェニルエーテル、2,2,2-トリフルオロエチルメタクリレート、2,2,3,3-テトラフルオロプロピルメタクリレート、2,2,3,4,4,4-ヘキサフルオロブチルメタクリレート、ノニルフェノールEO変性アクリレート、ノニルフェノールEO変性メタクリレートが挙げられる。 Examples of the monofunctional radically polymerizable compound other than the specific compound include 2-ethylhexyl acrylate, 1-butylethyl acrylate, 2-butoxyethyl acrylate, 2-cyanoethyl acrylate, benzyl acrylate, cyclohexyl acrylate, and 2-hydroxypropyl acrylate, 2 -Ethoxyethyl acrylate, N, N-diethyl-2-aminoethyl acrylate, N, N-dimethyl-2-aminoethyl acrylate, dicyclopentanyl acrylate, dicyclopentenyl acrylate, glycidyl acrylate, tetrahydrofurfuryl acrylate, isobol Nyl acrylate, isodecyl acrylate, lauryl acrylate, 4-acryloyl morpholine, 2-phenoxyethyl acrylate, diethylene glycol acrylate phenyl ether, 2,2,2-trifluoroethyl acrylate, 2,2,3,3,3-pentafluoropropyl Acrylate, 2,2,3,3-tetrafluoropropyl acrylate, 2,2,3,4,4,4-hexafluorobutyl acrylate, 2-ethylhexyl methacrylate, 1-butylethyl methacrylate, 2-butoxyethyl methacrylate, 2 -Cyanoethyl methacrylate, benzyl methacrylate, cyclohexyl methacrylate, 2-hydroxypropyl methacrylate, 2-ethoxyethyl acrylate, N, N-diethyl-2-aminoethyl methacrylate, N, N-dimethyl-2-aminoethyl methacrylate, dicyclopentanyl Methacrylate, dicyclopentenyl methacrylate, glycidyl methacrylate, tetrahydrofurfuryl methacrylate, isobornyl methacrylate, isodecyl methacrylate, lauryl methacrylate, 4-methacryloylmorpholine, 2-phenoxyethyl methacrylate, diethylene glycol methacrylate phenyl ether, 2,2,2-tri Examples thereof include fluoroethyl methacrylate, 2,2,3,3-tetrafluoropropyl methacrylate, 2,2,3,4,4,4-hexafluorobutyl methacrylate, nonylphenol EO modified acrylate, and nonylphenol EO modified methacrylate.
 より具体的には、NKエステルA-LEN-10、AM-90G、AM-130G、AMP-20GY、A-SA、S-1800A、CB-1、M-90G、M-230G、PHE-1G、S、SA(以上、新中村化学工業社製)、アロニックスM-111、M-120、M-140(以上、東亞合成社製)などが挙げられる。 More specifically, NK Ester A-LEN-10, AM-90G, AM-130G, AMP-20GY, A-SA, S-1800A, CB-1, M-90G, M-230G, PHE-1G, Examples thereof include S, SA (above, manufactured by Shin-Nakamura Chemical Industry Co., Ltd.), Aronix M-111, M-120, M-140 (above, manufactured by Toagosei Co., Ltd.) and the like.
 上記以外の単官能ラジカル重合性化合物として、接着層の硬化性と硬化収縮の点から、単官能の芳香族ウレタンアクリレートや脂肪族ウレタンアクリレートを含んでいても良い。 As the monofunctional radically polymerizable compound other than the above, monofunctional aromatic urethane acrylate or aliphatic urethane acrylate may be contained from the viewpoint of curability and curing shrinkage of the adhesive layer.
 また、上記以外の単官能ラジカル重合性化合物として、接着層と基材との密着性を高める点から、分子内にチオール基を有する化合物を含んでいても良い。具体的には1-デカンチオール、1-ドデカンチオール、1-ヘキサデカンチオール、1-オクタンチオール、1-オクタデカンチオールなどが挙げられる。 Further, as a monofunctional radically polymerizable compound other than the above, a compound having a thiol group in the molecule may be contained from the viewpoint of enhancing the adhesion between the adhesive layer and the substrate. Specific examples thereof include 1-decanethiol, 1-dodecanethiol, 1-hexadecanethiol, 1-octanethiol, 1-octadecanethiol and the like.
 更に、上記以外の単官能ラジカル重合性化合物として、接着層と基材との密着性を高める目的で、分子内にリン酸基を有する化合物を含むことが好ましい。分子内にリン酸基を有する単官能ラジカル重合性化合物として、具体的には、ホスマーM、PE、PP(以上、ユニケミカル社製)、ライトアクリレートP-1A(N)、ライトエステルP-1M(以上、共栄社化学社製)などが挙げられる。 Further, as the monofunctional radically polymerizable compound other than the above, it is preferable to contain a compound having a phosphoric acid group in the molecule for the purpose of enhancing the adhesion between the adhesive layer and the substrate. Specific examples of the monofunctional radically polymerizable compound having a phosphoric acid group in the molecule include Hosmer M, PE, PP (all manufactured by Unichemical Co., Ltd.), light acrylate P-1A (N), and light ester P-1M. (The above is manufactured by Kyoeisha Chemical Co., Ltd.).
 (A)成分には、特定化合物のみを用いることができるし、2種以上の特定化合物を混合して使用することもできる。また1種以上の特定化合物と、1種以上の特定化合物以外の単官能ラジカル重合性化合物とを混合して用いることも可能である。(A)成分のうち、特定化合物と特定化合物以外の単官能ラジカル重合性化合物との比率は、(A)成分を100質量部としたとき特定化合物を10質量部以上含むことが好ましい。 As the component (A), only a specific compound can be used, or two or more specific compounds can be mixed and used. It is also possible to mix and use one or more specific compounds and a monofunctional radically polymerizable compound other than one or more specific compounds. The ratio of the specific compound to the monofunctional radically polymerizable compound other than the specific compound among the components (A) is preferably 10 parts by mass or more when the component (A) is 100 parts by mass.
<(B)成分>
 (B)成分には、熱でラジカルが発生する熱ラジカル開始剤、及び紫外線でラジカルが発生する光ラジカル開始剤を用いることができる。これらは、硬化性組成物の硬化工程に応じて、適宜、選択される。
<Ingredient (B)>
As the component (B), a thermal radical initiator that generates radicals by heat and a photoradical initiator that generates radicals by ultraviolet rays can be used. These are appropriately selected depending on the curing step of the curable composition.
 熱でラジカルが発生する熱ラジカル開始剤としては、ケトンパーオキサイド構造、パーオキシケタール構造、ハイドロパーオキサイド構造、ジアルキルパーオキサイド構造、ジアシルパーオキサイド構造、パーオキシエステル構造、パーオキシジカーボネート構造、又はアゾ系構造を有する化合物などが挙げられる。なおラジカル発生時にガスが発生する熱ラジカル開始剤を用いると、空隙が発生する場合があるため、熱ラジカル開始剤としては、ケトンパーオキサイド構造、パーオキシケタール構造、ハイドロパーオキサイド構造、ジアルキルパーオキサイド構造、ジアシルパーオキサイド構造、パーオキシエステル構造又はパーオキシジカーボネート構造を有する化合物が好ましい。 Thermal radical initiators that generate radicals by heat include ketone peroxide structures, peroxyketal structures, hydroperoxide structures, dialkyl peroxide structures, diacyl peroxide structures, peroxyester structures, peroxydicarbonate structures, or Examples thereof include compounds having an azo-based structure. If a thermal radical initiator that generates gas when radicals are generated may generate voids, the thermal radical initiators include ketone peroxide structure, peroxyketal structure, hydroperoxide structure, and dialkyl peroxide. Compounds having a structure, a diacyl peroxide structure, a peroxy ester structure or a peroxy dicarbonate structure are preferable.
 具体的には、ジイソブチリルパーオキサイド、クミルパーオキシネオデカノエート、ジ-n-プロピルパーオキシジカーボネート、ジイソプロピルパーオキシジカーボネート、ジ-sec-ブチルパーオキシジカーボネート、1,1,3,3-テトラメチルブチルパーオキシネオデカネート、ビス(4-tert-ブチルシクロヘキシル)パーオキシジカーボネート、ビス(2-エチルヘキシル)パーオキシジカーボネート、tert-ヘキシルパーオキシネオデカノエート、tert-ブチルパーオキシネオデカノエート、tert-ブチルパーオキシネオヘプタノエート、tert-ヘキシルパーオキシピバレート、tert-ブチルパーオキシピバレート、ビス(3,5,5-トリメチルヘキサノイル)パーオキサイド、ジラウリルパーオキサイド、1,1,3,3-テトラメチルブチルパーオキシ-2-エチルヘキサノエート、ジスクシン酸パーオキサイド、2,5-ジメチル-2,5-ビス(2-エチルヘキサノイルパーオキシ)ヘキサン、tert-ヘキシルパーオキシ-2-エチルヘキサノエート、ジ(4-メチルベンゾイル)パーオキサイド、tert-ブチルパーオキシ-2-エチルヘキサノエート、ジベンゾイルパーオキサイド、1,1-ビス(t-ブチルパーオキシ)-2-メチルシクロヘキサン、1,1-ビス(tert-ヘキシルパーオキシ)-3,3,5-トリメチルシクロヘキサン、1,1-ビス(tert-ヘキシルパーオキシ)シクロヘキサン、1,1-ビス(tert-ブチルパーオキシ)シクロヘキサン、2,2-ビス(4,4-ジ-(tert-ブチルパーオキシ)シクロヘキシル)プロパン、tert-ヘキシルパーオキシイソプロピルモノカーボネート、tert-ブチルパーオキシマレイン酸、tert-ブチルパーオキシ-3,5,5-トリメチルヘキサノエート、tert-ブチルパーオキシラウレート、tert-ブチルパーオキシイソプロピルモノカーボネート、tert-ブチルパーオキシ-2-エチルヘキシルモノカーボネート、tert-ヘキシルパーオキシベンゾエート、2,5-ジメチル-2,5-ビス(ベンゾイルパーオキシ)ヘキサン、tert-ブチルパーオキシアセテート、2,2-ビス(tert-ブチルパーオキシ)ブタン、tert-ブチルパーオキシベンゾエート、n-ブチル-4,4-ビス(tert-ブチルパーオキシ)バレレート、1,4-ビス(tert-ブチルパーオキシイソプロピル)ベンゼン、ジクミルパーオキサイド、ジ-tert-ヘキシルパーオキサイド、2,5-ジメチル-2,5-ビス(tert-ブチルパーオキシ)ヘキサン、tert-ブチルクミルパーオキサイド、ジ-tert-ブチルパーオキサイド、p-メンタンヒドロパーオキサイド、2,5-ジメチル-2,5-ビス(tert-ブチルパーオキシ)-3-ヘキシン、ジイソプロピルベンゼンヒドロパーオキサイド、1,1,3,3-テトラメチルブチルヒドロパーオキサイド、クメンヒドロパーオキサイド、及びtert-ブチルヒドロパーオキサイドなどが挙げられる。 Specifically, diisobutyryl peroxide, cumylperoxyneodecanoate, di-n-propylperoxydicarbonate, diisopropylperoxydicarbonate, di-sec-butylperoxydicarbonate, 1,1,3. 3-Tetramethylbutyl peroxyneodecanate, bis (4-tert-butylcyclohexyl) peroxydicarbonate, bis (2-ethylhexyl) peroxydicarbonate, tert-hexylperoxyneodecanoate, tert-butylper Oxyneodecanoate, tert-butylperoxyneoheptanoate, tert-hexylperoxypivalate, tert-butylperoxypivalate, bis (3,5,5-trimethylhexanoyl) peroxide, dilaurylper Oxide, 1,1,3,3-tetramethylbutylperoxy-2-ethylhexanoate, dissuccinic acid peroxide, 2,5-dimethyl-2,5-bis (2-ethylhexanoylperoxy) hexane, tert-Hexylperoxy-2-ethylhexanoate, di (4-methylbenzoyl) peroxide, tert-butylperoxy-2-ethylhexanoate, dibenzoyl peroxide, 1,1-bis (t-butyl) Peroxy) -2-methylcyclohexane, 1,1-bis (tert-hexylperoxy) -3,3,5-trimethylcyclohexane, 1,1-bis (tert-hexylperoxy) cyclohexane, 1,1-bis (Tert-Butylperoxy) cyclohexane, 2,2-bis (4,4-di- (tert-butylperoxy) cyclohexyl) propane, tert-hexylperoxyisopropyl monocarbonate, tert-butylperoxymaleic acid, tert -Butylperoxy-3,5,5-trimethylhexanoate, tert-butylperoxylaurate, tert-butylperoxyisopropyl monocarbonate, tert-butylperoxy-2-ethylhexylmonocarbonate, tert-hexylperoxy Benzoate, 2,5-dimethyl-2,5-bis (benzoylperoxy) hexane, tert-butylperoxyacetate, 2,2-bis (tert-butylperoxy) butane, tert-butylperoxybenzoate, n- Butyl-4,4-bis (tert-butylperoxy) ballere , 1,4-bis (tert-butylperoxyisopropyl) benzene, dicumyl peroxide, di-tert-hexyl peroxide, 2,5-dimethyl-2,5-bis (tert-butylperoxy) hexane , Tert-Butyl cumyl peroxide, di-tert-butyl peroxide, p-menthan hydroperoxide, 2,5-dimethyl-2,5-bis (tert-butylperoxy) -3-hexine, diisopropylbenzenehydroper Examples include oxides, 1,1,3,3-tetramethylbutylhydroperoxide, cumenehydroperoxide, tert-butylhydroperoxide and the like.
 より具体的には、パーロイルIB、パークミルND、パーロイルNPP、パーロイルIPP、パーロイルSBP、パーオクタND、パーロイルTCP、パーロイルOPP、パーヘキシルND、パーブチルND、パーブチルNHP、パーヘキシルPV、パーブチルPV、パーロイル355、パーロイルL、パーオクタO、パーロイルSA、パーヘキサ25O、パーヘキシルO、ナイパーPMB、パーブチルO、ナイパーBMT、ナイパーBW、パーヘキサMC、パーヘキサTMH、パーヘキサHC、パーヘキサC、パーテトラA、パーヘキシルI、パーブチルMA、パーブチル355、パーブチルL、パーブチルI、パーブチルE、パーヘキシルZ、パーヘキサ25Z、パーブチルA、パーヘキサ22、パーブチルZ、パーヘキサV、パーブチルP、パークミルD、パーヘキシルD、パーヘキサ25B、パーブチルC、パーブチルD、パーメンタH、パーヘキシン25B、パークミルP、パーオクタH、パークミルH、パーブチルH、又はノフマーBC(以上、日油社製)などが挙げられる。 More specifically, parloyl IB, park mill ND, parloyl NPP, parloyl IPP, parloyl SBP, perocta ND, parloyl TCP, parloyl OPP, perhexyl ND, perbutyl ND, perbutyl NHP, perhexyl PV, perbutyl PV, perloyl 355, parloyl L. , Perocta O, Perloyl SA, Perhexa 25O, Perhexil O, Niper PMB, Perbutyl O, Niper BMT, Niper BW, Perhexa MC, Perhexa TMH, Perhexa HC, Perhexa C, Pertetra A, Perhexyl I, Perbutyl MA, Perbutyl 355, Perbutyl L, Perbutyl I, Perbutyl E, Perhexyl Z, Perhexa 25Z, Perbutyl A, Perhexa 22, Perbutyl Z, Perhexa V, Perbutyl P, Park Mill D, Perhexil D, Perhexil 25B, Perbutyl C, Perbutyl D, Permenta H, Perhexin 25B, Examples thereof include Park Mill P, Per Octa H, Park Mill H, Perbutyl H, and Novmer BC (all manufactured by NOF CORPORATION).
 なかでも、反応性や反応開始温度の点から、ビス(4-tert-ブチルシクロヘキシル)パーオキシジカーボネート(パーロイルTCP/日油社製)、tert-ブチルパーオキシピバレート(パーブチルPV/日油社製)、1,1,3,3-テトラメチルブチルパーオキシ-2-エチルヘキサノエート(パーオクタO/日油社製)、1,1-ビス(tert-ヘキシルパーオキシ)シクロヘキサン(パーヘキサHC/日油社製)、2,5-ジメチル-2,5-ジ(ベンゾイルパーオキシ)ヘキサン(パーヘキサ25Z/日油社製)、tert-ブチルパーオキシベンゾエート(パーブチルZ/日油社製)及び1,4-ビス(tert-ブチルパーオキシイソプロピル)ベンゼン(パーブチルP/日油社製)を用いることが好ましい。 Among them, bis (4-tert-butylcyclohexyl) peroxydicarbonate (parloyl TCP / manufactured by Nichiyu Co., Ltd.) and tert-butylperoxypivalate (perbutyl PV / Nichiyu Co., Ltd.) are particularly important in terms of reactivity and reaction start temperature. , 1,1,3,3-Tetramethylbutylperoxy-2-ethylhexanoate (PeroctaO / manufactured by Nichiyu Co., Ltd.), 1,1-bis (tert-hexylperoxy) cyclohexane (Perhexa HC /) (Nippon Oil Co., Ltd.), 2,5-dimethyl-2,5-di (benzoylperoxy) hexane (Perhexa 25Z / Nichiyu Co., Ltd.), tert-butyl peroxybenzoate (Perbutyl Z / Nichiyu Co., Ltd.) and 1 , 4-Bis (tert-butylperoxyisopropyl) benzene (Perbutyl P / manufactured by Nichiyu Co., Ltd.) is preferably used.
 熱ラジカル開始剤の使用割合は、硬化性組成物の保存安定性と硬化性の点から、(A)成分を含めたすべてのラジカル重合性化合物100質量部に対して、0.01~10質量部であることが好ましい。より好ましいのは、0.05~5質量部である。また、これら熱ラジカル開始剤は、上記特性に応じて、1種類又は2種類以上を混合して使用することもできる。 The ratio of the thermal radical initiator used is 0.01 to 10% by mass with respect to 100 parts by mass of all the radically polymerizable compounds including the component (A) from the viewpoint of storage stability and curability of the curable composition. It is preferably a radical. More preferred is 0.05 to 5 parts by mass. Further, these thermal radical initiators may be used alone or in combination of two or more, depending on the above-mentioned characteristics.
 紫外線でラジカルが発生する光ラジカル開始剤としては、2,2-ジメトキシ-1,2-ジフェニルエタン-1-オン、1-ヒドロキシシクロヘキシルフェニルケトン、2-ヒドロキシ-2-メチル-1-フェニルプロパン-1-オン、1-[4-(2-ヒドロキシエトキシ)フェニル]-2-ヒドロキシ-2-メチルプロパン-1-オン、2-ヒドロキシ-1-{4-[4-(2-ヒドロキシ-2-メチルプロピオニル)-ベンジル]フェニル}-2-メチルプロパン-1-オン、2-メチル-1-(4-メチルチオフェニル)-2-モルフォリノプロパン-1-オン、2-(ジメチルアミノ)-2-[(4-メチルフェニル)メチル]-1-[4-(4-モルホニル)フェニル]-1-ブタノン、2,4,6-トリメチルベンゾイルジフェニルフォスフィンオキサイド、ビス(2,4,6-トリメチルベンゾイル)フェニルフォスフィンオキサイド、1-[4-(フェニルチオ)フェニル]オクタン-1,2-ジオン=2-(O-ベンゾイルオキシム)]、1-[9-エチル-6-(2-メチルベンゾイル)-9H-カルバゾール-3-イル]-エタノン=1-(O-アセチルオキシム)、メチルベンゾイルフォルメート、オキシ-フェニル-酢酸2-[2-オキソ-2-フェニル-アセトキシ-エトキシ]エチルエステルとオキシフェニルアセチック-2-[2-ヒドロキシ-エトキシ]エチルエステルの混合物、又は2-ベンジル-2-(ジメチルアミノ)-1-[4-(4-モルフォリニル)フェニル]-1-ブタノンなどが挙げられる。 Examples of photoradical initiators that generate radicals with ultraviolet rays include 2,2-dimethoxy-1,2-diphenylethane-1-one, 1-hydroxycyclohexylphenylketone, and 2-hydroxy-2-methyl-1-phenylpropane-. 1-on, 1- [4- (2-hydroxyethoxy) phenyl] -2-hydroxy-2-methylpropane-1-one, 2-hydroxy-1- {4- [4- (2-hydroxy-2-) Methylpropionyl) -benzyl] phenyl} -2-methylpropan-1-one, 2-methyl-1- (4-methylthiophenyl) -2-morpholinopropane-1-one, 2- (dimethylamino) -2- [(4-Methylphenyl) Methyl] -1- [4- (4-morphonyl) phenyl] -1-butanone, 2,4,6-trimethylbenzoyldiphenylphosphinoxide, bis (2,4,6-trimethylbenzoyl) ) Phenylphosphine oxide, 1- [4- (phenylthio) phenyl] octane-1,2-dione = 2- (O-benzoyloxime)], 1- [9-ethyl-6- (2-methylbenzoyl)- 9H-Carbazole-3-yl] -etanone = 1- (O-acetyloxime), methylbenzoylformate, oxy-phenyl-acetic acid 2- [2-oxo-2-phenyl-acetoxy-ethoxy] ethyl ester and oxyphenyl Examples thereof include a mixture of acetic-2- [2-hydroxy-ethoxy] ethyl ester, 2-benzyl-2- (dimethylamino) -1- [4- (4-morpholinyl) phenyl] -1-butanone, and the like.
 より具体的には、Omnirad1173、184、127、2959、369、379、389、907、4265、1000、651、TPO-H、TPO-L、819、819DW、2022、2100、754、OXE-01、OXE-02、OXE-03、OXE-04、BPFlakes、4MBZFlakes、OMBB、1601、BMS、ITX、DETX、BBF、EMK、EsacureKIP150、KIP100F、又はTZTなどが挙げられる(以上、IGM Resins社製)。 More specifically, Omnirad1173, 184, 127, 2959, 369, 379, 389, 907, 4265, 1000, 651, TPO-H, TPO-L, 819, 819DW, 2022, 2100, 754, OXE-01, Examples thereof include OXE-02, OXE-03, OXE-04, BPFlakes, 4MBZFlakes, OMBB, 1601, BMS, ITX, DETX, BBF, EMK, EscaleKIP150, KIP100F, TZT and the like (above, manufactured by IGM Resins).
 なかでも、反応性や波長選択性の点から、1-ヒドロキシシクロヘキシルフェニルケトン(Omnirad184/IGM Resins社製)、2-ヒドロキシ-2-メチル-1-フェニルプロパン-1-オン(Omnirad1173/IGM Resins社製)、2-ベンジル-2-(ジメチルアミノ)-1-[4-(4-モルフォリニル)フェニル]-1-ブタノン(Omnirad369/IGM Resins社製)、2-メチル-1-(4-メチルチオフェニル)-2-モルフォリノプロパン-1-オン(Omnirad907/IGM Resins社製)、ビス(2,4,6-トリメチルベンゾイル)フェニルフォスフィンオキサイド(Omnirad819/IGM Resins社製)、2,4,6-トリメチルベンゾイル-ジフェニルフォスフィンオキサイド(OmniradTPO-H/IGM Resins社製)、OmniradTPO-L/IGM Resins社製、1-[4-(フェニルチオ)フェニル]オクタン-1,2-ジオン=2-(O-ベンゾイルオキシム)](O-アセチルオキシム)(OmniradOXE01/IGM Resins社製)、及び1-[9-エチル-6-(2-メチルベンゾイル)-9H-カルバゾール-3-イル]-エタノン=2,1-(O-アセチルオキシム)(OmniradOXE02/IGM Resins社製)を用いることが好ましい。 Among them, 1-hydroxycyclohexylphenyl ketone (Omnirad 184 / IGM Resins), 2-hydroxy-2-methyl-1-phenylpropan-1-one (Omnirad 1173 / IGM Resins) from the viewpoint of reactivity and wavelength selectivity. , 2-benzyl-2- (dimethylamino) -1- [4- (4-morpholinyl) phenyl] -1-butanone (Omnirad369 / IGM Resins), 2-methyl-1- (4-methylthiophenyl) )-2-Morphorinopropan-1-one (Omnirad907 / IGM Resins), Bis (2,4,6-trimethylbenzoyl) Phenylphosphinoxide (Omnirad819 / IGM Resins), 2,4,6- Trimethylbenzoyl-diphenylphosphine oxide (Omnirad TPO-H / IGM Resins), Omnirad TPO-L / IGM Resins, 1- [4- (Phenylthio) phenyl] octane-1,2-dione = 2- (O-) (Benzoyl oxime)] (O-acetyl oxime) (OmniradOXE01 / IGM Resins), and 1- [9-ethyl-6- (2-methylbenzoyl) -9H-carbazole-3-yl] -etanone = 2,1 -(O-Acetyloxym) (OmniradOXE02 / IGM Resins) is preferably used.
 光ラジカル開始剤の使用割合は、接着層の硬化性の点から、(A)成分を含めたすべてのラジカル重合性化合物100質量部に対して、0.01~10質量部であることが好ましい。より好ましいのは、0.05~5質量部である。また、これら光ラジカル開始剤は、硬化処理で使用する光源の波長と接着層の硬化性に応じて、1種又は2種類以上を混合して使用することができる。 The ratio of the photoradical initiator used is preferably 0.01 to 10 parts by mass with respect to 100 parts by mass of all the radically polymerizable compounds including the component (A) from the viewpoint of curability of the adhesive layer. .. More preferred is 0.05 to 5 parts by mass. Further, these photoradical initiators can be used alone or in combination of two or more depending on the wavelength of the light source used in the curing treatment and the curability of the adhesive layer.
<(C)成分>
 本発明においては、接着層の硬化性及び膜強度の点から、(C)成分として、ラジカルで反応する官能基を分子内に2つ以上有する、2官能以上のラジカル重合性化合物(以下、多官能ラジカル重合性化合物と称する)を用いることも好ましい。
<Ingredient (C)>
In the present invention, from the viewpoint of curability and film strength of the adhesive layer, a bifunctional or more radically polymerizable compound having two or more radical-reacting functional groups in the molecule as the component (C) (hereinafter, many). It is also preferable to use (referred to as a functional radically polymerizable compound).
 具体的には、下記の多官能ラジカル重合性化合物が挙げられる。
 例えば、4,4’-ビフェニルジアクリレート、ジエチルスチルベストロールジアクリレート、1,4-ビスアクリロイルオキシベンゼン、4,4’-ビスアクリロイルオキシジフェニルエーテル、4,4’-ビスアクリロイルオキシジフェニルメタン、3,9-[1,1-ジメチル-2-アクリロイルオキシエチル]-2,4,8,10-テトラスピロ[5,5]ウンデカン、α,α’-ビス[4-アクリロイルオキシフェニル]-1,4-ジイソプロピルベンゼン、1,4-ビスアクリロイルオキシテトラフルオロベンゼン、4,4’-ビスアクリロイルオキシオクタフルオロビフェニル、ジエチレングリコールジアクリレート、1,4-ブタンジオールジアクリレート、1,3-ブチレングリコールジアクリレート、グリセロールジアクリレート、1,6-ヘキサンジオールジアクリレート、ネオペンチルグリコールジアクリレート、テトラエチレングリコールジアクリレート、トリメチロールプロパントリアクリレート、ペンタエリスリトールテトラアクリレート、ペンタエリスリトールトリアクリレート、ジトリメチロールプロパンテトラアクリレート、ジペンタエリスリトールヘキサアクリレート、ジペンタエリスリトールモノヒドロキシペンタアクリレート、4,4’-ジアクリロイルオキシスチルベン、4,4’-ジアクリロイルオキシジメチルスチルベン、4,4’-ジアクリロイルオキシジエチルスチルベン、4,4’-ジアクリロイルオキシジプロピルスチルベン、4,4’-ジアクリロイルオキシジブチルスチルベン、4,4’-ジアクリロイルオキシジペンチルスチルベン、4,4’-ジアクリロイルオキシジヘキシルスチルベン、4,4’-ジアクリロイルオキシジフルオロスチルベン、2,2,3,3,4,4-ヘキサフルオロペンタンジオール-1,5-ジアクリレート、1,1,2,2,3,3-ヘキサフルオロプロピル-1,3-ジアクリレート、ジエチレングリコールジメタクリレート、1,4-ブタンジオールジメタクリレート、1,3-ブチレングリコールジメタクリレート、1,6-ヘキサンジオールジメタクリレート、ネオペンチルグリコールジメタクリレート、テトラエチレングリコールジメタクリレート、トリメチロールプロパントリメタクリレート、ペンタエリスリトールテトラメタクリレート、ペンタエリスリトールトリメタクリレート、ジトリメチロールプロパンテトラメタクリレート、ジペンタエリスリトールヘキサメタクリレート、ジペンタエリスリトールモノヒドロキシペンタメタクリレート、2,2,3,3,4,4-ヘキサフルオロペンタンジオール-1,5-ジメタクリレート、トリシクロデカンジメタノールジアクリレート、トリシクロデカンジメタノールジメタクリレート、ジプロピレングリコールジアクリレート、トリプロピレングリコールジアクリレート、ポリプロピレングリコール♯400ジアクリレート、ポリプロピレングリコール♯700ジアクリレート、ジプロピレングリコールジメタクリレート、トリプロピレングリコールジメタクリレート、ポリプロピレングリコール♯400ジメタクリレート、ポリプロピレングリコール♯700ジメタクリレート、ポリエチレングリコール♯200ジアクリレート、ポリエチレングリコール♯400ジアクリレート、ポリエチレングリコール♯600ジアクリレート、ポリエチレングリコール♯200ジメタクリレート、ポリエチレングリコール♯400ジメタクリレート、ポリエチレングリコール♯600ジメタクリレート、エトキシ化ビスフェノールAジアクリレート、プロポキシ化ビスフェノールAジアクリレート、エトキシ化ビスフェノールAジメタクリレート、プロポキシ化ビスフェノールAジメタクリレート、又はエトキシ化ペンタエリスリトールテトラアクリレートなどのモノマー、及びオリゴマーなどが挙げられる。
Specific examples thereof include the following polyfunctional radically polymerizable compounds.
For example, 4,4'-biphenyldiacrylate, diethylstillbestrol diacrylate, 1,4-bisacryloyloxybenzene, 4,4'-bisacryloyloxydiphenyl ether, 4,4'-bisacryloyloxydiphenylmethane, 3,9 -[1,1-dimethyl-2-acryloyloxyethyl] -2,4,8,10-tetraspiro [5,5] undecane, α, α'-bis [4-acryloyloxyphenyl] -1,4-diisopropyl Benzene, 1,4-bisacryloyloxytetrafluorobenzene, 4,4'-bisacryloyloxyoctafluorobiphenyl, diethylene glycol diacrylate, 1,4-butanediol diacrylate, 1,3-butylene glycol diacrylate, glycerol diacrylate , 1,6-hexanediol diacrylate, neopentyl glycol diacrylate, tetraethylene glycol diacrylate, trimethylol propanetriacrylate, pentaerythritol tetraacrylate, pentaerythritol triacrylate, ditrimethylolpropanetetraacrylate, dipentaerythritol hexaacrylate, Dipentaerythritol monohydroxypentaacrylate, 4,4'-diacryloyloxystylben, 4,4'-diacryloyloxydimethylstylben, 4,4'-diacryloyloxydiethylsylben, 4,4'-diacryloyloxydipropyl Stillben, 4,4'-diacryloyloxydibutylstilben, 4,4'-diacryloyloxydipentylstylben, 4,4'-diacryloyloxydihexylstilben, 4,4'-diacryloyloxydifluorostilben, 2,2 3,3,4,4-hexafluoropentanediol-1,5-diacrylate, 1,1,2,2,3,3-hexafluoropropyl-1,3-diacrylate, diethylene glycol dimethacrylate, 1,4 -Butanediol dimethacrylate, 1,3-butylene glycol dimethacrylate, 1,6-hexanediol dimethacrylate, neopentyl glycol dimethacrylate, tetraethylene glycol dimethacrylate, trimethylolpropanetrimethacrylate, pentaerythritol tetramethacrylate, pentaerythritoltri Methacrylate, Ditrimethylol Propa Ntetramethacrylate, dipentaerythritol hexamethacrylate, dipentaerythritol monohydroxypentamethacrylate, 2,2,3,3,4,4-hexafluoropentanediol-1,5-dimethacrylate, tricyclodecanedimethanol diacrylate, Tricyclodecanedimethanol dimethacrylate, dipropylene glycol diacrylate, tripropylene glycol diacrylate, polypropylene glycol # 400 diacrylate, polypropylene glycol # 700 diacrylate, dipropylene glycol dimethacrylate, tripropylene glycol dimethacrylate, polypropylene glycol # 400 Dimethacrylate, Polypropylene Glycol # 700 Dimethacrylate, Polyethylene Glycol # 200 Diacrylate, Polyethylene Glycol # 400 Diacrylate, Polyethylene Glycol # 600 Diacrylate, Polyethylene Glycol # 200 Dimethacrylate, Polyethylene Glycol # 400 Dimethacrylate, Polyethylene Glycol # 600 Dimethacrylate Examples include monomers such as methacrylate, ethoxylated bisphenol A diacrylate, propoxylated bisphenol A diacrylate, ethoxylated bisphenol A dimethacrylate, propoxyylated bisphenol A dimethacrylate, or ethoxylated pentaerythritol tetraacrylate, and oligomers.
 より具体的には、NKエステル701A、A-200、A-400、A-600、A-1000、A-B1206PE、ABE-300、A-BPE-10、A-BPE-20、A-BPE-30、A-BPE-4、A-BPEF、A-BPP-3、A-DCP、A-DOD-N、A-HD-N、A-NOD-N、APG-100、APG-200、APG-400、APG-700、A-PTMG-65、A-9300、A-9300-1CL、A-GLY-9E、A-GLY-20E、A-TMM-3、A-TMM-3L、A-TMM-3LM-N、A-TMPT、AD-TMP、ATM-35E、A-TMMT、A-9550、A-DPH、1G、2G、3G、4G、9G、14G、23G、BPE-80N、BPE-100、BPE-200、BPE-500、BPE-900、BPE-1300N、DCP、DOD-N、HD-N、NOD-N、NPG、1206PE、701、9PG、TMPT(以上、新中村化学工業社製)、KAYARADFM-400、HX-220、HX-620、R-712(以上、日本化薬社製)、ブレンマーPDE-100、PDE-200、PDE-400、PDP-400N、ADE-200、ADE-300、ADE-400A、又はADP-400(以上、日油社製)などが挙げられる。 More specifically, NK Ester 701A, A-200, A-400, A-600, A-1000, AB1206PE, ABE-300, A-BPE-10, A-BPE-20, A-BPE- 30, A-BPE-4, A-BPEF, A-BPP-3, A-DCP, A-DOD-N, A-HD-N, A-NOD-N, APG-100, APG-200, APG- 400, APG-700, A-PTMG-65, A-9300, A-9300-1CL, A-GLY-9E, A-GLY-20E, A-TMM-3, A-TMM-3L, A-TMM- 3LM-N, A-TMPT, AD-TMP, ATM-35E, A-TMMT, A-9550, A-DPH, 1G, 2G, 3G, 4G, 9G, 14G, 23G, BPE-80N, BPE-100, BPE-200, BPE-500, BPE-900, BPE-1300N, DCP, DOD-N, HD-N, NOD-N, NPG, 1206PE, 701, 9PG, TMPT (all manufactured by Shin Nakamura Chemical Industry Co., Ltd.), KAYARADFM-400, HX-220, HX-620, R-712 (all manufactured by Nippon Kayaku Co., Ltd.), Blemmer PDE-100, PDE-200, PDE-400, PDP-400N, ADE-200, ADE-300, Examples thereof include ADE-400A or ADP-400 (all manufactured by NOF CORPORATION).
 なかでも、接着層の膜強度及び硬化収縮の点から、トリシクロデカンジメタノールジアクリレート、トリシクロデカンジメタノールジメタクリレート、ポリエチレングリコール♯200ジアクリレート、ポリエチレングリコール♯400ジアクリレート、ポリエチレングリコール♯600ジアクリレート、ポリエチレングリコール♯200ジメタクリレート、ポリエチレングリコール♯400ジメタクリレート、ポリエチレングリコール♯600ジメタクリレート、トリプロピレングリコールジアクリレート、ポリプロピレングリコール♯400ジアクリレート、ポリプロピレングリコール♯700ジアクリレート、トリプロピレングリコールジメタクリレート、ポリプロピレングリコール♯400ジメタクリレート、ポリプロピレングリコール♯700ジメタクリレート、エトキシ化ビスフェノールAジアクリレート、エトキシ化ビスフェノールAジメタクリレート、KAYARADFM-400、HX-220、及びHX-620(以上、日本化薬社製)が好ましい。 Among them, tricyclodecanedimethanol diacrylate, tricyclodecanedimethanol dimethacrylate, polyethylene glycol # 200 diacrylate, polyethylene glycol # 400 diacrylate, and polyethylene glycol # 600 diacrylate from the viewpoint of film strength and curing shrinkage of the adhesive layer. Acrylic, Polyethylene Glycol # 200 Dimethacrylate, Polyethylene Glycol # 400 Dimethacrylate, Polyethylene Glycol # 600 Dimethacrylate, Tripropylene Glycol Diacrylate, Polypropylene Glycol # 400 Diacrylate, Polypropylene Glycol # 700 Diacrylate, Tripropylene Glycol Dimethacrylate, Polypropylene Glycol # 400 dimethacrylate, polypropylene glycol # 700 dimethacrylate, ethoxylated bisphenol A diacrylate, ethoxylated bisphenol A dimethacrylate, KAYARADFM-400, HX-220, and HX-620 (all manufactured by Nippon Kayaku Co., Ltd.) are preferable. ..
 (C)成分には、接着層の硬化性と硬化収縮の点から、芳香族ウレタン多官能アクリレートや脂肪族ウレタン多官能アクリレートを含むことが好ましい。具体的には、EBECRYL210、220、230、270、4858、8402、8804、8807、9270、4513、4738、4740、8311、9260、8701、4265、4587、4666、8210、1290、5129、8301R、4501、2221、1271、4859、8409、8465、8809、8810、8811、4101、4201、8209、1291、8602、225、KRM8191、8667、8296、8200、8904、又は8452(以上、ダイセル・オルネクス社製)などが挙げられる。 The component (C) preferably contains an aromatic urethane polyfunctional acrylate or an aliphatic urethane polyfunctional acrylate from the viewpoint of curability and curing shrinkage of the adhesive layer. Specifically, EBECRYL210, 220, 230, 270, 4858, 8402, 8804, 8807, 9270, 4513, 4738, 4740, 8311, 9260, 8701, 4265, 4587, 4666, 8210, 1290, 5129, 8301R, 4501. , 2221, 1271, 4859, 8409, 8465, 8809, 8810, 8811, 4101, 4201, 8209, 1291, 8602, 225, KRM8911, 8667, 8296, 8200, 8904, or 8452 (all manufactured by Daisel Ornex). And so on.
 なかでも、接着層の透明性の点から、脂肪族ウレタン多官能アクリレートのEBECRYL230、4858、8402、8804、8807、4859、8465、8809及び8811(以上、ダイセル・オルネクス社製)を含むことが好ましい。 Among them, from the viewpoint of the transparency of the adhesive layer, it is preferable to include the aliphatic urethane polyfunctional acrylates EBECRYL230, 4858, 8402, 8804, 8807, 4859, 8465, 8809 and 8811 (all manufactured by Dycel Ornex). ..
 また、(C)成分には、接着層と基材との密着性を高める点から、分子内にチオール基を有する多官能ラジカル重合性化合物を含むことが好ましい。具体的には、トリメチロールプロパントリス(3-メルカプトプロピオネート)、トリス-[(3-メルカプトプロピオニルオキシ)-エチル]-イソシアヌレート、ペンタエリスリトールテトラキス(3-メルカプトプロピオネート)、テトラエチレングリコールビス(3-メルカプトプロピオネート)、ジペンタエリストールヘキサキス(3-メルカプトプロピオネート)、トリメチロールプロパントリス(3-メルカプトブチレート)、トリメチロールエタントリス(3-メルカプトブチレート)、ペンタエリスリトールテトラキス(3-メルカプトブチレート)、1,3,5-トリス(3-メルカプトブチリルオキシエチル)-1,3,5-トリアジン-2,4,6-(1H,3H,5H)-トリオン、ネオペンタンテトラチオール、ペンタエリトリトールテトラキス(3-メルカプトプロピオネート)、及びジペンタエリスリトールヘキサキス(3-メルカプトプロピオネート)などが挙げられる。より具体的には、カレンズMTPE1、BD1、NR1、及びTPMB(以上、昭和電工社製)が挙げられる。なかでも、カレンズMTPE1、BD1、及びNR1(以上、昭和電工社製)を含むことが好ましい。
 分子内にチオール基を有する多官能ラジカル重合性化合物の配合比率は、(A)成分及び(C)成分の合計100質量部に対して、0.05~10質量部が好ましく、0.1~5質量部がより好ましい。
 なお、チオール基を有する化合物は、ラジカル重合の連鎖移動剤として働く。そして、分子内にチオール基を1つ有する化合物の残基は、通常、開始剤と同様に重合鎖の末端に存在する。しかし、分子内にチオール基を2以上有する化合物を用いた場合、単に連鎖移動剤として働くのみではなく、分子内の2つ以上のチオール基から成長反応が生じる結果、当該化合物の残基は重合鎖の途中に存在する。更に、分子内にチオール基を3以上有する化合物を用いた場合、分子内の3つ以上のチオール基から成長反応が生じる結果、当該化合物の残基は重合鎖の架橋点ともなりうる。そのため、本発明においては、分子内にチオール基を2以上有する化合物は多官能ラジカル重合性化合物に含まれるものとする。
Further, the component (C) preferably contains a polyfunctional radically polymerizable compound having a thiol group in the molecule from the viewpoint of enhancing the adhesion between the adhesive layer and the substrate. Specifically, trimethylolpropanetris (3-mercaptopropionate), tris-[(3-mercaptopropionyloxy) -ethyl] -isosyanurate, pentaerythritol tetrakis (3-mercaptopropionate), tetraethylene glycol. Bis (3-mercaptopropionate), dipentaerythritol hexakis (3-mercaptopropionate), trimethylolpropanetris (3-mercaptobutyrate), trimethylol ethanetris (3-mercaptobutyrate), penta Elythritol tetrakis (3-mercaptobutyrate), 1,3,5-tris (3-mercaptobutyryloxyethyl) -1,3,5-triazine-2,4,6- (1H, 3H, 5H) -trion , Neopentanetetrathiol, pentaerythritol tetrakis (3-mercaptopropionate), dipentaerythritol hexakis (3-mercaptopropionate) and the like. More specifically, Karenz MTPE1, BD1, NR1, and TPMB (all manufactured by Showa Denko KK) can be mentioned. Among them, it is preferable to include Calends MTPE1, BD1 and NR1 (all manufactured by Showa Denko KK).
The blending ratio of the polyfunctional radically polymerizable compound having a thiol group in the molecule is preferably 0.05 to 10 parts by mass, preferably 0.1 to 10 parts by mass, based on 100 parts by mass of the total of the components (A) and (C). 5 parts by mass is more preferable.
The compound having a thiol group acts as a chain transfer agent for radical polymerization. The residue of the compound having one thiol group in the molecule is usually present at the end of the polymerized chain like the initiator. However, when a compound having two or more thiol groups in the molecule is used, the residue of the compound is polymerized as a result of not only acting as a chain transfer agent but also a growth reaction occurring from two or more thiol groups in the molecule. It exists in the middle of the chain. Furthermore, when a compound having 3 or more thiol groups in the molecule is used, a growth reaction occurs from the 3 or more thiol groups in the molecule, and as a result, the residue of the compound can also be a cross-linking point of the polymer chain. Therefore, in the present invention, the compound having two or more thiol groups in the molecule is included in the polyfunctional radically polymerizable compound.
 更に、接着層と基材との密着性を高める目的で、分子内にリン酸基を有する多官能ラジカル重合性化合物を用いてもよい。具体的には、KAYAMERPM-2、又はPM-21(以上、日本化薬社製)などが挙げられる。
 分子内にリン酸基を含む多官能ラジカル重合性化合物の配合比率は、(A)成分及び(C)成分の合計100質量部に対して、0.01~3質量部が好ましく、0.05~2質量部がより好ましい。
Further, a polyfunctional radically polymerizable compound having a phosphoric acid group in the molecule may be used for the purpose of enhancing the adhesion between the adhesive layer and the substrate. Specific examples thereof include KAYAMER PM-2 or PM-21 (all manufactured by Nippon Kayaku Co., Ltd.).
The blending ratio of the polyfunctional radically polymerizable compound containing a phosphoric acid group in the molecule is preferably 0.01 to 3 parts by mass, preferably 0.05 with respect to 100 parts by mass of the total of the components (A) and (C). ~ 2 parts by mass is more preferable.
 (C)成分には、これら多官能ラジカル重合性化合物の1種類又は2種類以上を混合して使用することができる。 One or more of these polyfunctional radically polymerizable compounds can be used as the component (C).
<硬化性組成物>
 硬化性組成物は、(A)成分及び(B)成分を含有する。その際、接着層の硬化性及び膜強度の点から、(C)成分を含有しても良い。
<Curable composition>
The curable composition contains the component (A) and the component (B). At that time, the component (C) may be contained from the viewpoint of curability and film strength of the adhesive layer.
 (A)成分と(C)成分とを含有した場合の(A)成分の配合比率は、(A)成分及び(C)成分の合計100質量部に対して、10~99質量部が好ましい。なかでも、20~95質量部がより好ましく、更に好ましいのは、40~90質量部である。また、(C)成分は、(A)成分及び(C)成分の合計100質量部に対して、1質量部以上含まれていることが好ましい。なかでも、5質量部以上含まれていることがより好ましく、更に好ましいのは、10質量部以上である。また、(A)成分と(C)成分とを含有した場合の(C)成分の配合比率は、(A)成分及び(C)成分の合計100質量部に対して、90質量部以下であることが好ましく、80質量部以下であることがより好ましく、60質量部以下であることが更に好ましい。
 また、(A)成分と(C)成分とを含有した場合の上記式[1]で表される化合物の配合比率は、(A)成分及び(C)成分の合計100質量部に対して、10~99質量部が好ましい。なかでも、20~95質量部がより好ましく、更に好ましいのは、40~90質量部である。
When the component (A) and the component (C) are contained, the blending ratio of the component (A) is preferably 10 to 99 parts by mass with respect to a total of 100 parts by mass of the component (A) and the component (C). Of these, 20 to 95 parts by mass is more preferable, and 40 to 90 parts by mass is even more preferable. Further, it is preferable that the component (C) is contained in an amount of 1 part by mass or more with respect to a total of 100 parts by mass of the component (A) and the component (C). Among them, 5 parts by mass or more is more preferable, and 10 parts by mass or more is more preferable. Further, when the component (A) and the component (C) are contained, the blending ratio of the component (C) is 90 parts by mass or less with respect to a total of 100 parts by mass of the component (A) and the component (C). It is preferably 80 parts by mass or less, more preferably 60 parts by mass or less.
Further, the compounding ratio of the compound represented by the above formula [1] when the component (A) and the component (C) are contained is based on 100 parts by mass of the total of the component (A) and the component (C). 10 to 99 parts by mass is preferable. Of these, 20 to 95 parts by mass is more preferable, and 40 to 90 parts by mass is even more preferable.
 硬化性組成物は、25℃での粘度が1~10000mPa・sとなるように、(A)成分、(B)成分及び(C)成分の配合比率を調整することが好ましい。なお、下記に示す各種塗布方法に適用するため、25℃の粘度が1~500mPa・sであることが好ましい。なかでも、寸法制御を維持し、硬化性組成物を塗布又は硬化した際に生じるムラを低減する観点から、1~300mPa・sがより好ましく、更に好ましいのは、1~100mPa・sである。
 硬化性組成物の調製方法としては、(A)成分、(B)成分及び(C)成分を一緒に混合する方法や、予め、(A)成分と(C)成分とを混合したものに、(B)成分を混合する方法が挙げられる。
It is preferable to adjust the blending ratio of the component (A), the component (B) and the component (C) so that the curable composition has a viscosity at 25 ° C. of 1 to 10000 mPa · s. In addition, in order to apply to various coating methods shown below, it is preferable that the viscosity at 25 ° C. is 1 to 500 mPa · s. Among them, 1 to 300 mPa · s is more preferable, and 1 to 100 mPa · s is more preferable, from the viewpoint of maintaining dimensional control and reducing unevenness generated when the curable composition is applied or cured.
As a method for preparing the curable composition, a method of mixing the component (A), the component (B) and the component (C) together, or a method in which the component (A) and the component (C) are mixed in advance may be used. (B) A method of mixing the components can be mentioned.
 硬化性組成物には、溶媒を加えてワニス状にして使用することもできる。これにより、基材への塗布性を向上させ、加工性を高めることができる。その際の溶媒としては、(A)成分、(B)成分及び(C)成分が均一に溶解するものであれば特に限定されず、公知のものを用いることができる。具体的には、メタノール、エタノール、イソプロピルアルコール、アセトン、トルエン、テトラヒドロフラン、ヘキサン、酢酸エチル、1-ブタノール、2-メトキシエタノール、2-エトキシエタノール、シクロヘキサノン、プロピレングリコールモノメチルエーテルアセテート、N-メチル-2-ピロリドン、及びγ-ブチロラクトンなどが挙げられる。これらは、1種類又は2種類以上を混合して使用することができる。ただし、溶媒由来のガス発生を低減させる必要がある場合は、溶媒を加えないことが好ましい。 The curable composition can be used as a varnish by adding a solvent. As a result, the applicability to the base material can be improved and the processability can be improved. The solvent at that time is not particularly limited as long as the component (A), the component (B) and the component (C) are uniformly dissolved, and known solvents can be used. Specifically, methanol, ethanol, isopropyl alcohol, acetone, toluene, tetrahydrofuran, hexane, ethyl acetate, 1-butanol, 2-methoxyethanol, 2-ethoxyethanol, cyclohexanone, propylene glycol monomethyl ether acetate, N-methyl-2. -Pyrrolidone, γ-butyrolactone and the like can be mentioned. These can be used alone or in admixture of two or more. However, when it is necessary to reduce the generation of gas derived from the solvent, it is preferable not to add the solvent.
 硬化性組成物には、無機フィラーや有機フィラーを含有しても良い。なかでも、接着層の耐熱性を高める点で、無機フィラーを用いることが好ましい。無機フィラーには、公知のものが挙げられ、例えば、水酸化アルミニウム、水酸化マグネシウム、窒化ホウ素、結晶性シリカ、及び非晶性シリカなどが挙げられる。これらは、1種類又は2種類以上を混合して使用することができる。 The curable composition may contain an inorganic filler or an organic filler. Above all, it is preferable to use an inorganic filler from the viewpoint of increasing the heat resistance of the adhesive layer. Examples of the inorganic filler include known ones, and examples thereof include aluminum hydroxide, magnesium hydroxide, boron nitride, crystalline silica, and amorphous silica. These can be used alone or in admixture of two or more.
 硬化性組成物には、接着層の間隙(ギャップともいう。)を制御するためのスペーサーを導入することもできる。 A spacer for controlling the gap (also referred to as a gap) of the adhesive layer can be introduced into the curable composition.
 硬化性組成物は、例えば、接着剤として用いることができる。
 本発明の硬化物は、本発明の硬化性組成物又は接着剤から得られる。硬化物は、例えば、後述する硬化性組成物の硬化処理により得られる。
The curable composition can be used, for example, as an adhesive.
The cured product of the present invention is obtained from the curable composition or adhesive of the present invention. The cured product is obtained, for example, by a curing treatment of a curable composition described later.
<接着層の作製方法>
 硬化性組成物は、基材と基材とを貼り合わせる、基材に部材をくっつける、又は液晶表示素子や有機EL素子同士をくっつける接着剤として用いることができる。接着方法としては、例えば、一方の被着体(基材)の接着面に上記硬化性組成物を塗布する工程、上記被着体の接着面にもう一方の被着体(基材又は部材)を貼り付ける工程、さらに上記硬化性組成物を硬化させる工程、を含む方法が挙げられる。また、本発明の硬化性組成物を接着剤として用いる場合、環境、安全及び健康上の観点から、上記接着剤は溶媒を実質的に含まない無溶媒接着剤であってもよい。ここで、実質的に含まないとは、硬化性組成物の全量100質量部中に、溶媒を0~0.5質量部、好ましくは0~0.2質量部含有することをいう。さらに本発明の硬化性組成物は、硬化性組成物を塗布して硬化させ、絶縁膜などの硬化膜として用いることもできる。
<Method of manufacturing the adhesive layer>
The curable composition can be used as an adhesive for adhering a base material to a base material, attaching a member to the base material, or attaching a liquid crystal display element or an organic EL element to each other. Examples of the bonding method include a step of applying the curable composition to the adhesive surface of one adherend (base material), and the other adherend (base material or member) to the adhesive surface of the adherend. A method including a step of pasting the adhesive and a step of curing the curable composition can be mentioned. When the curable composition of the present invention is used as an adhesive, the adhesive may be a solvent-free adhesive that does not substantially contain a solvent from the viewpoints of environment, safety and health. Here, "substantially free" means that the total amount of the curable composition is 100 parts by mass, and 0 to 0.5 parts by mass, preferably 0 to 0.2 parts by mass of the solvent is contained. Further, the curable composition of the present invention can also be used as a cured film such as an insulating film by applying the curable composition and curing it.
 硬化性組成物を基材に塗布する方法としては、スピンコート法、スリットコート法、ロールコート法、インクジェット法、スクリーン印刷法、バーコート法、フレキソ印刷法、グラビア印刷法、ダイコート法、及びディスペンス法などが挙げられる。これらは、基材の種類や目的とする接着層の厚みに応じて、適宜、選択される。本発明の硬化性組成物は、粘度が低いことから、インクジェットでの塗布に最適である。 The methods for applying the curable composition to the substrate include spin coating method, slit coating method, roll coating method, inkjet method, screen printing method, bar coating method, flexographic printing method, gravure printing method, die coating method, and dispense. The law etc. can be mentioned. These are appropriately selected according to the type of the base material and the thickness of the target adhesive layer. The curable composition of the present invention has a low viscosity and is therefore most suitable for application by inkjet.
 硬化性組成物の硬化処理はラジカル開始剤の種類によって、適宜、選択される。 The curing treatment of the curable composition is appropriately selected depending on the type of radical initiator.
 熱ラジカル開始剤を用いた硬化性組成物の場合は、次の方法が挙げられる。上記方法で硬化性組成物を塗布し、基材と基材とを貼り合わせ、或いは基材に部材を貼り付けた後に、加熱処理をする。その際に用いる加熱機器としては、ホットプレート、熱循環型オーブン及びIR(赤外線)型オーブンなどが挙げられ、酸素が存在すると硬化阻害が発生することから、窒素雰囲気や真空下など酸素を除いた状態であることが好ましい。また、加熱処理の際は基材同士又は基材と部材とを圧着することが好ましい。 In the case of a curable composition using a thermal radical initiator, the following methods can be mentioned. The curable composition is applied by the above method, and the base material is bonded to the base material, or the member is attached to the base material, and then heat treatment is performed. Examples of the heating device used at that time include a hot plate, a heat circulation type oven, an IR (infrared) type oven, etc. Since curing inhibition occurs in the presence of oxygen, oxygen is removed in a nitrogen atmosphere or under vacuum. It is preferably in a state. Further, in the heat treatment, it is preferable to press the base materials against each other or between the base material and the member.
 光ラジカル開始剤を用いた硬化性組成物の場合は、次の方法が挙げられる。上記方法で硬化性組成物を塗布した後、もう一方の基材を貼り合わせ、或いは部材を貼り付け、紫外線を照射する方法がある。その際、上記と同様に、窒素雰囲気や真空下などであることが好ましい。また、貼り合わせ又は貼り付けの精度を高めるため、仮硬化工程として、硬化性組成物を塗布した後、塗布後の硬化性組成物の層に紫外線を照射し、もう一方の基材を貼り合わせる、或いは部材を貼り付けて、本硬化処理を行う方法がある。仮硬化工程の紫外線の照射は、大気下で行うことが好ましい。また、本硬化処理としては、紫外線の照射、或いは加熱処理が挙げられる。紫外線の照射量及び加熱処理の温度は、基材の種類及びラジカル開始剤の種類によって、適宜、選択される。紫外線照射及び加熱処理は窒素雰囲気下で行われることが好ましい。酸素濃度は、100mg/L未満に制御しても良い。 In the case of a curable composition using a photoradical initiator, the following methods can be mentioned. After applying the curable composition by the above method, there is a method of laminating the other base material or pasting a member and irradiating with ultraviolet rays. At that time, similarly to the above, it is preferable to have a nitrogen atmosphere or a vacuum. Further, in order to improve the accuracy of bonding or bonding, as a temporary curing step, after applying the curable composition, the layer of the cured composition after coating is irradiated with ultraviolet rays, and the other substrate is bonded. Alternatively, there is a method of pasting a member to perform the main curing treatment. Irradiation of ultraviolet rays in the temporary curing step is preferably performed in the atmosphere. In addition, examples of the main curing treatment include irradiation with ultraviolet rays or heat treatment. The irradiation amount of ultraviolet rays and the temperature of the heat treatment are appropriately selected depending on the type of the substrate and the type of the radical initiator. It is preferable that the ultraviolet irradiation and the heat treatment are performed in a nitrogen atmosphere. The oxygen concentration may be controlled to less than 100 mg / L.
 本発明の硬化性組成物の硬化前に対する硬化後の硬化収縮率は、低いほど好ましく、本実施形態では9.0%以下であることが好ましく、より好ましくは8.5%以下である。
 硬化収縮率は、後述する「硬化収縮率の評価」に記載の方法で求めることができる。
The lower the curing shrinkage rate after curing of the curable composition of the present invention, the more preferably 9.0% or less, and more preferably 8.5% or less in the present embodiment.
The curing shrinkage rate can be determined by the method described in "Evaluation of curing shrinkage rate" described later.
 紫外線の照射に用いる紫外線照射装置の光源としては、メタルハライドランプ、高圧水銀ランプ、及びLED光源などが挙げられる。その際、紫外線の波長は、250~450nmが好ましい。なかでも、310~400nmがより好ましい。
 紫外線の照度は、生産性を向上する観点から、1~50mW/cmの範囲にすることが好ましい。紫外線の照射量は、硬化を十分にする観点から、50mJ/cm~30000mJ/cmの範囲にすることが好ましい。
Examples of the light source of the ultraviolet irradiation device used for irradiating ultraviolet rays include a metal halide lamp, a high-pressure mercury lamp, and an LED light source. At that time, the wavelength of ultraviolet rays is preferably 250 to 450 nm. Of these, 310 to 400 nm is more preferable.
The illuminance of ultraviolet rays is preferably in the range of 1 to 50 mW / cm 2 from the viewpoint of improving productivity. The irradiation amount of ultraviolet rays is preferably in the range of 50 mJ / cm 2 to 30,000 mJ / cm 2 from the viewpoint of sufficient curing.
 被着体の基材としては、酸化物・窒化物(例えば、石英、ガラス、シリカ、チタニア、アルミナ、サファイア、アルミノケイ酸ガラス、ホウケイ酸ガラス、窒化珪素、SiON、ITO、IZO、及びIGZOなど)、プラスチック(例えば、ポリメチルメタクリレート、ポリエチレンテレフタレート、ポリブチレンテレフタレート、ポリエチレンナフタレート、ABS、ポリカーボネート、ポリスチレン、エポキシ、不飽和ポリエステル、メラミン、ジアリルフタレート、ポリイミド、ウレタン、ナイロン、ポリエチレン、ポリプロピレン、シクロオレフィンポリマー、ポリ塩化ビニル、フッ素樹脂(ポリテトラフルオロエチレン樹脂、ポリクロロトリフルオロエチレン樹脂、ポリフッ化ビニリデン樹脂、ポリフッ化ビニル樹脂、ペルフルオロアルコキシフッ素樹脂、四フッ化エチレン・六フッ化プロピレン共重合体樹脂、エチレン・四フッ化エチレン共重合体樹脂、エチレン・クロロトリフルオロエチレン共重合体樹脂など)、ポリブタジエン、ポリイソプレン、SBR、ニトリルラバー、EPM、EPDM、エピクロルヒドリンラバー、ネオプレンラバー、ポルサルファイド、ブチルラバー、セルロース、セルロース誘導体、及びセルロース類似体など)、金属(例えば、鉄、アルミニウム、ステンレス、チタン、金、銀、銅、亜鉛、モリブデン、及びこれらの合金など)の基板、シートフィルムが挙げられる。 As the base material of the adherend, oxides / nitrides (for example, quartz, glass, silica, titania, alumina, sapphire, aluminosilicate glass, borosilicate glass, silicon nitride, SiON, ITO, IZO, IGZO, etc.) , Plastics (eg, polymethylmethacrylate, polyethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate, ABS, polycarbonate, polystyrene, epoxy, unsaturated polyester, melamine, diallyl phthalate, polyimide, urethane, nylon, polyethylene, polypropylene, cycloolefin polymer , Polyvinyl chloride, fluororesin (polytetrafluoroethylene resin, polychlorotrifluoroethylene resin, polyfluorovinylidene resin, polyvinylfluorovinyl resin, perfluoroalkoxyfluororesin, tetrafluoroethylene / hexafluoropropylene copolymer resin, Ethylene / tetrafluoroethylene copolymer resin, ethylene / chlorotrifluoroethylene copolymer resin, etc.), polybutadiene, polyisoprene, SBR, nitrile rubber, EPM, EPDM, epichlorohydrin rubber, neoprene rubber, porsulfide, butyl rubber, Examples include substrates of metals (eg, iron, aluminum, stainless steel, titanium, gold, silver, copper, zinc, molybdenum, and alloys thereof), sheet films, etc. (such as cellulose, cellulose derivatives, and cellulose analogs).
 なかでも、光学素子用途として、酸化物・窒化物には、ガラス、シリカ、アルミナ、アルミノケイ酸ガラス、ホウケイ酸ガラス、窒化珪素、SiON、及びITOが好ましい。プラスチックには、ポリメチルメタクリレート、ポリエチレンテレフタレート、ポリカーボネート、及びポリイミドが好ましい。金属には、アルミニウム、銀、銅、モリブデン、及びこれらの合金が好ましい。 Among them, glass, silica, alumina, aluminosilicate glass, borosilicate glass, silicon nitride, SiON, and ITO are preferable for the oxide / nitride for optical element applications. The plastic is preferably polymethylmethacrylate, polyethylene terephthalate, polycarbonate, and polyimide. Aluminum, silver, copper, molybdenum, and alloys thereof are preferable as the metal.
 本発明の光学素子は、本発明の硬化性組成物を用いて得られる。
 また、本発明の光学素子は、本発明の接着剤を用いて得られる。
The optical element of the present invention is obtained by using the curable composition of the present invention.
Further, the optical element of the present invention can be obtained by using the adhesive of the present invention.
 硬化性組成物は、電子デバイスの封止材料としても、好適に用いることができる。電子デバイスとしては、有機EL素子、有機薄膜太陽電池、及び発光ダイオード素子などが挙げられる。電子デバイスの封止方法としては、公知の手法を用いることができる。具体的には、硬化性組成物を基材や部材の上に、スピンコート法やインクジェット法で塗布した後、加熱処理又は紫外線を照射して硬化させることで電子デバイスを封止することができる。
 また、硬化性組成物は、液晶表示素子、有機ELディスプレイ、量子ドットディスプレイなどに、アクリル板、透明性ポリイミド樹脂などのプラスチック板やタッチパネルセンサーを貼り付ける際の接着剤として用いることもできる。その際、液晶表示素子、有機ELディスプレイ、量子ドットディスプレイなどの表示素子同士を貼り合わせる際にも用いることができる。
The curable composition can also be suitably used as a sealing material for electronic devices. Examples of the electronic device include an organic EL element, an organic thin-film solar cell, and a light emitting diode element. As a method for sealing the electronic device, a known method can be used. Specifically, the curable composition can be applied onto a base material or a member by a spin coating method or an inkjet method, and then heat-treated or irradiated with ultraviolet rays to cure the electronic device. ..
Further, the curable composition can also be used as an adhesive for attaching a plastic plate such as an acrylic plate or a transparent polyimide resin or a touch panel sensor to a liquid crystal display element, an organic EL display, a quantum dot display or the like. At that time, it can also be used when bonding display elements such as a liquid crystal display element, an organic EL display, and a quantum dot display.
 以下に実施例を挙げ、本発明をさらに詳しく説明するが、これらに限定されるものではない。 The present invention will be described in more detail with reference to examples below, but the present invention is not limited thereto.
[特定化合物の合成]
 A1からA5は文献等未公開の新規化合物であり、以下に合成法を詳述する。
[Synthesis of specific compound]
A1 to A5 are novel compounds that have not been published in the literature, and the synthetic method will be described in detail below.
 下記実施例1~5に記載の生成物(A1~A5)はH-NMR分析により同定した(分析条件は下記の通り)。
 装置:BRUKER ADVANCE III-500MHz
 測定溶媒:DMSO-d,CDCl
 基準物質:テトラメチルシラン(TMS)(δ0.0 ppm for H)
The products (A1 to A5) described in Examples 1 to 5 below were identified by 1 H-NMR analysis (analytical conditions are as follows).
Equipment: BRUKER ADVANCE III-500MHz
Measuring solvent: DMSO-d 6 , CDCl 3
Reference substance: Tetramethylsilane (TMS) (δ0.0 ppm for 1 H)
 本発明における略号はそれぞれ以下の意味を示す。
 EDC・HCl:1-(3-ジメチルアミノプロピル)-3-エチルカルボジイミド塩酸塩
 DMAP:4-ジメチルアミノピリジン
The abbreviations in the present invention have the following meanings.
EDC ・ HCl: 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride DMAP: 4-dimethylaminopyridine
<実施例1 特定化合物(A1)の合成>
Figure JPOXMLDOC01-appb-C000014
<Example 1 Synthesis of specific compound (A1)>
Figure JPOXMLDOC01-appb-C000014
 2-ヒドロキシエチルメタクリレート(13.0g,99.9mmol)に対し、2,2,4,8,10,10-ヘキサメチルウンデカン-5-カルボン酸(30.0g,105mmol)、塩化メチレン(78g)、EDC・HCl(23.0g,120mmol)、及びDMAP(1.22g,9.99mmol)を仕込み、25℃で20時間撹拌した。反応終了後、撹拌を停止し、水(80g)を加えて分液洗浄し、飽和炭酸水素ナトリウム水溶液(80g)で分液洗浄し、水(80g)で分液洗浄した。有機層を濃縮し、薄黄色オイルを得た。精製はカラムクロマトグラフィー(展開溶媒:ヘプタン/酢酸エチル=4/1(体積比))にて行い、溶媒除去を行うことにより、特定化合物(A1)を得た(収量:37g,93.3mmol,収率:98%)。
 H-NMR(500MHz/DMSO-d):δ(ppm)=6.03(s,1H),5.69(s,1H),4.35-4.20(m,4H),2.18-2.11(m,1H),1.87(s,3H),1.79-0.72(m,34H).
2-Hydroxyethyl methacrylate (13.0 g, 99.9 mmol), 2,2,4,8,10,10-hexamethylundecane-5-carboxylic acid (30.0 g, 105 mmol), methylene chloride (78 g) , EDC.HCl (23.0 g, 120 mmol), and DMAP (1.22 g, 9.99 mmol) were charged and stirred at 25 ° C. for 20 hours. After completion of the reaction, stirring was stopped, water (80 g) was added and washed separately, washed with saturated aqueous sodium hydrogen carbonate solution (80 g), and washed with water (80 g). The organic layer was concentrated to give a pale yellow oil. Purification was performed by column chromatography (developing solvent: heptane / ethyl acetate = 4/1 (volume ratio)), and the solvent was removed to obtain a specific compound (A1) (yield: 37 g, 93.3 mmol, Yield: 98%).
1 1 H-NMR (500 MHz / DMSO-d 6 ): δ (ppm) = 6.03 (s, 1H), 5.69 (s, 1H), 4.35-4.20 (m, 4H), 2 .18-2.11 (m, 1H), 1.87 (s, 3H), 1.79-0.72 (m, 34H).
<実施例2 特定化合物(A2)の合成>
Figure JPOXMLDOC01-appb-C000015
<Example 2 Synthesis of specific compound (A2)>
Figure JPOXMLDOC01-appb-C000015
 ポリエチレングリコールモノメタクリレート(商品名:ブレンマーPE-90,日油社製)(16.0g,91.8mmol)に対し、2,2,4,8,10,10-ヘキサメチルウンデカン-5-カルボン酸(26.4g,92.8mmol)、塩化メチレン(96g)、EDC・HCl(26.4g,138mmol)、及びDMAP(1.12g,9.17mmol)を仕込み、25℃で10日間撹拌した。反応終了後、撹拌を停止し、水(96g)を加えて分液洗浄し、飽和炭酸水素ナトリウム水溶液(96g)で分液洗浄し、水(96g)で分液洗浄した。有機層を濃縮し、薄黄色オイルを得た。精製はカラムクロマトグラフィー(展開溶媒:酢酸エチル)にて行い、溶媒除去を行うことにより、特定化合物(A2)を得た(収量:35g,79.4mmol,収率:87%)。
 H-NMR(500MHz/DMSO-d):δ(ppm)=6.03(s,1H),5.69(m,1H),4.39-4.05(m,4H),3.70-3.45(m,4H),2.30-2.09(m,2H),1.88(s,3H),1.80-0.72(m,33H).
2,2,4,8,10,10-hexamethylundecane-5-carboxylic acid with respect to polyethylene glycol monomethacrylate (trade name: Blemmer PE-90, manufactured by NOF CORPORATION) (16.0 g, 91.8 mmol). (26.4 g, 92.8 mmol), methylene chloride (96 g), EDC / HCl (26.4 g, 138 mmol), and DMAP (1.12 g, 9.17 mmol) were charged and stirred at 25 ° C. for 10 days. After completion of the reaction, stirring was stopped, water (96 g) was added and washed separately, washed with saturated aqueous sodium hydrogen carbonate solution (96 g), and washed with water (96 g). The organic layer was concentrated to give a pale yellow oil. Purification was performed by column chromatography (developing solvent: ethyl acetate), and the solvent was removed to obtain the specific compound (A2) (yield: 35 g, 79.4 mmol, yield: 87%).
1 1 H-NMR (500 MHz / DMSO-d 6 ): δ (ppm) = 6.03 (s, 1H), 5.69 (m, 1H), 4.39-4.05 (m, 4H), 3 .70-3.45 (m, 4H), 2.30-2.09 (m, 2H), 1.88 (s, 3H), 1.80-0.72 (m, 33H).
<実施例3 特定化合物(A3)の合成>
Figure JPOXMLDOC01-appb-C000016
<Example 3 Synthesis of specific compound (A3)>
Figure JPOXMLDOC01-appb-C000016
 2-(4,4-ジメチル-2-ペンタニル)-5,7,7-トリメチル-1-オクタノール(40.0g,148mmol)に対し、コハク酸無水物(30.0g,300mmol)、酢酸エチル(240g)、ピリジン(26.0g,325mmol)、及びDMAP(1.80g,14.8mmol)を仕込み、90℃で5時間撹拌した。撹拌を停止し25℃へ冷却後、水(120g)で3回分液洗浄して有機層を濃縮し、オイル及び一部析出した白色結晶混合物を得た。これにヘプタン(230g)を加え25℃で30分撹拌して濾過することで、白色結晶を除去し、濾液に対し1規定塩酸(230g)で2回分液洗浄し、有機層を濃縮・乾燥させ、化合物(1)を得た(収量:54g,146mmol,収率:99%)。
 H-NMR(500MHz/DMSO-d):δ(ppm)=12.2(s,1H),4.00-3.83(m,2H),2.53-2.53(m,4H),1.62-1.73(m,1H),1.49-0.72(m,34H).
2- (4,4-dimethyl-2-pentanyl) -5,7,7-trimethyl-1-octanol (40.0 g, 148 mmol), succinic anhydride (30.0 g, 300 mmol), ethyl acetate ( 240 g), pyridine (26.0 g, 325 mmol), and DMAP (1.80 g, 14.8 mmol) were charged and stirred at 90 ° C. for 5 hours. After stopping stirring and cooling to 25 ° C., the mixture was washed three times with water (120 g) to concentrate the organic layer, and an oil and a partially precipitated white crystal mixture were obtained. Heptane (230 g) is added thereto, and the mixture is stirred at 25 ° C. for 30 minutes and filtered to remove white crystals. The filtrate is washed twice with 1N hydrochloric acid (230 g), and the organic layer is concentrated and dried. , Compound (1) was obtained (yield: 54 g, 146 mmol, yield: 99%).
1 1 H-NMR (500 MHz / DMSO-d 6 ): δ (ppm) = 12.2 (s, 1H), 4.00-3.83 (m, 2H), 2.53-2.53 (m, 4H), 1.62-1.73 (m, 1H), 1.49-0.72 (m, 34H).
 次に、化合物(1)(54.0g,146mmol)に対し、2-ヒドロキシエチルメタクリレート(19.3g,148mmol)、塩化メチレン(326g)、EDC・HCl(33.7g,176mmol)、及びDMAP(1.80g,14.7mmol)を仕込み、25℃で21時間撹拌した。反応終了後、撹拌を停止し、水(326g)、及び飽和食塩水(54g)を加えて分液洗浄し、飽和炭酸水素ナトリウム水溶液(272g)、及び飽和食塩水(109g)で2回分液洗浄し、有機層(一部水層込)を濃縮した。ヘプタン(320g)を加え分液抽出し、再度有機層を濃縮した。精製はカラムクロマトグラフィー(展開溶媒:ヘプタン/酢酸エチル=4/1(体積比))にて行い、溶媒除去を行うことにより、特定化合物(A3)を得た(収量:57g,118mmol,収率:80%)。
 H-NMR(500MHz/DMSO-d):δ(ppm)=6.03(s,1H),5.67(s,1H),4.27(s,4H),3.97-3.85(m,2H),2.56-2.54(m,4H),1.87(s,3H),1.70-1.60(m,1H),1.49-0.72(m,34H).
Next, for compound (1) (54.0 g, 146 mmol), 2-hydroxyethyl methacrylate (19.3 g, 148 mmol), methylene chloride (326 g), EDC / HCl (33.7 g, 176 mmol), and DMAP ( 1.80 g, 14.7 mmol) was charged, and the mixture was stirred at 25 ° C. for 21 hours. After completion of the reaction, stirring is stopped, water (326 g) and saturated brine (54 g) are added for separate liquid washing, and saturated aqueous sodium hydrogen carbonate solution (272 g) and saturated brine (109 g) are used for separate liquid washing. Then, the organic layer (including a part of the aqueous layer) was concentrated. Heptane (320 g) was added and the liquid was separated and extracted, and the organic layer was concentrated again. Purification was performed by column chromatography (developing solvent: heptane / ethyl acetate = 4/1 (volume ratio)), and the solvent was removed to obtain the specific compound (A3) (yield: 57 g, 118 mmol, yield). : 80%).
1 1 H-NMR (500 MHz / DMSO-d 6 ): δ (ppm) = 6.03 (s, 1H), 5.67 (s, 1H), 4.27 (s, 4H), 3.97-3 .85 (m, 2H), 2.56-2.54 (m, 4H), 1.87 (s, 3H), 1.70-1.60 (m, 1H), 1.49-0.72 (M, 34H).
<実施例4 特定化合物(A4)の合成>
Figure JPOXMLDOC01-appb-C000017
<Example 4 Synthesis of specific compound (A4)>
Figure JPOXMLDOC01-appb-C000017
 2-ヒドロキシエチルメタクリレート(16.9g,130mmol)に対し、2-ヘキシルデカン酸(40.0g,156mmol)、塩化メチレン(240g)、EDC・HCl(29.9g,156mmol)、及びDMAP(1.59g,13.0mmol)を仕込み、25℃で4日間撹拌した。反応終了後、撹拌を停止し、水(80g)を加えて分液洗浄し、有機層を濃縮した。ヘプタン(240g)を加え、飽和炭酸水素ナトリウム水溶液(240g)、ジメチルスルホキシド(240g)、及び水(240g)でそれぞれ分液洗浄し、有機層を濃縮した。得られたオイルに対し、カラムクロマトグラフィー(展開溶媒:ヘプタン/酢酸エチル=4/1(体積比))にて精製を行い、溶媒除去を行うことにより、特定化合物(A4)を得た(収量:46g,124mmol,収率:95%)。
 H-NMR(500MHz/CDCl):δ(ppm)=6.13(s,1H),5.58(s,1H),4.34-4.32(m,4H),2.39-2.32(m,1H),1.94(s,3H),1.65-1.57(m,2H),1.45-1.43(m,2H),1.31-1.09(m,20H),0.88-0.87(m,6H).
2-Hydroxyethyl methacrylate (16.9 g, 130 mmol) vs. 2-hexyldecanoic acid (40.0 g, 156 mmol), methylene chloride (240 g), EDC / HCl (29.9 g, 156 mmol), and DMAP (1.59 g). , 13.0 mmol) was charged, and the mixture was stirred at 25 ° C. for 4 days. After completion of the reaction, stirring was stopped, water (80 g) was added, and the liquid was separated and washed to concentrate the organic layer. Heptane (240 g) was added, and the mixture was washed separately with saturated aqueous sodium hydrogen carbonate solution (240 g), dimethyl sulfoxide (240 g), and water (240 g) to concentrate the organic layer. The obtained oil was purified by column chromatography (developing solvent: heptane / ethyl acetate = 4/1 (volume ratio)) and the solvent was removed to obtain a specific compound (A4) (yield). : 46 g, 124 mmol, yield: 95%).
1 1 H-NMR (500 MHz / CDCl 3 ): δ (ppm) = 6.13 (s, 1H), 5.58 (s, 1H), 4.34-4.32 (m, 4H), 2.39 -2.32 (m, 1H), 1.94 (s, 3H), 1.65-1.57 (m, 2H), 1.45-1.43 (m, 2H), 1.31-1 .09 (m, 20H), 0.88-0.87 (m, 6H).
<実施例5 特定化合物の混合物(A5)の合成>
Figure JPOXMLDOC01-appb-C000018
<Example 5 Synthesis of a mixture (A5) of a specific compound>
Figure JPOXMLDOC01-appb-C000018
 2-ヒドロキシエチルメタクリレート(15.2g,117mmol)に対し、2-オクチルデカン酸及び2-ヘキシルドデカン酸の混合物(商品名:イソステアリン酸T,日産化学社製)(40.0g,141mmol)、塩化メチレン(240g)、EDC・HCl(27.0g,141mmol)、及びDMAP(1.43g,11.7mmol)を仕込み、25℃で24時間撹拌した。反応終了後、撹拌を停止し、水(240g)を加えて分液洗浄し、有機層を濃縮した。ヘプタン(240g)を加え、飽和炭酸水素ナトリウム水溶液(240g)、ジメチルスルホキシド(240g)、及び水(240g)の順でそれぞれ分液洗浄し、有機層を濃縮した。得られたオイルに対し、カラムクロマトグラフィー(展開溶媒:ヘプタン/酢酸エチル=4/1)にて精製を行い、溶媒除去を行うことにより、特定化合物の混合物(A5)を得た(収量:42g,106mmol,収率:91%)。
 H-NMR(500MHz/CDCl):δ(ppm)=6.12(s,1H),5.58(s,1H),4.35-4.34(m,4H),2.39-2.32(m,1H),1.95(s,3H),1.67-1.57(m,2H),1.45-1.43(m,2H),1.31-1.11(m,24H),0.89-0.86(m,6H).
Mixture of 2-octyldecanoic acid and 2-hexyldodecanoic acid (trade name: Isostearic acid T, manufactured by Nissan Chemical Industries, Ltd.) (40.0 g, 141 mmol), chloride with respect to 2-hydroxyethyl methacrylate (15.2 g, 117 mmol). Methylene (240 g), EDC / HCl (27.0 g, 141 mmol), and DMAP (1.43 g, 11.7 mmol) were charged and stirred at 25 ° C. for 24 hours. After completion of the reaction, stirring was stopped, water (240 g) was added, and the liquid was separated and washed to concentrate the organic layer. Heptane (240 g) was added, and the saturated aqueous sodium hydrogen carbonate solution (240 g), dimethyl sulfoxide (240 g), and water (240 g) were separated and washed in this order to concentrate the organic layer. The obtained oil was purified by column chromatography (developing solvent: heptane / ethyl acetate = 4/1) and the solvent was removed to obtain a mixture (A5) of a specific compound (yield: 42 g). , 106 mmol, yield: 91%).
1 1 H-NMR (500MHz / CDCl 3 ): δ (ppm) = 6.12 (s, 1H), 5.58 (s, 1H), 4.35-4.34 (m, 4H), 2.39 -2.32 (m, 1H), 1.95 (s, 3H), 1.67-1.57 (m, 2H), 1.45-1.43 (m, 2H), 1.31-1 .11 (m, 24H), 0.89-0.86 (m, 6H).
[硬化性組成物の調製に用いる化合物類]
<特定化合物>
 A1~A5:それぞれ、上記実施例で得られた化合物及び混合物
<特定化合物以外の単官能ラジカル重合性化合物>
 A6:アロニックスM-111(ノニルフェノールEO変性アクリレート)(東亞合成社製)
<ラジカル開始剤>
 B1:パーヘキサ25Z(日油社製)/熱ラジカル開始剤
 B2:OmniradTPO-H(IGM Resins社製)/光ラジカル開始剤
 B3:OmniradOXE01(IGM Resins社製)/光ラジカル開始剤
<2官能以上のラジカル重合性化合物>
 C1:ブレンマーPDE-200(ポリエチレングリコール#200ジメタクリレート)(日油社製)
 C2:NKエステルDCP(トリシクロデカンジメタノールジメタクリレート)(新中村化学工業社製)
 C3:EBECRYL230(ダイセル・オルネクス社製)/ウレタンアクリレート
 C4:EBECRYL9270(ダイセル・オルネクス社製)/ウレタンアクリレート
 C5:カレンズMTBD1(昭和電工社製)/チオール基を有する重合性化合物
 C6:カレンズMTPE1(昭和電工社製)/チオール基を有する重合性化合物
 C7:KAYAMER PM-21(日本化薬社製)/リン酸基を有する重合性化合物
[Compounds used for preparation of curable composition]
<Specific compound>
A1 to A5: Compounds and mixtures obtained in the above Examples, respectively <monofunctional radically polymerizable compounds other than specific compounds>
A6: Aronix M-111 (nonylphenol EO-modified acrylate) (manufactured by Toagosei Co., Ltd.)
<Radical initiator>
B1: Perhexa 25Z (manufactured by NOF Corporation) / Thermal radical initiator B2: OmniradTPO-H (manufactured by IGM Resins) / Photo-radical initiator B3: OmniradOXE01 (manufactured by IGM Resins) / Photo-radical initiator <2 functional or higher Radical polymerizable compound>
C1: Blemmer PDE-200 (polyethylene glycol # 200 dimethacrylate) (manufactured by NOF CORPORATION)
C2: NK ester DCP (tricyclodecanedimethanol dimethacrylate) (manufactured by Shin Nakamura Chemical Industry Co., Ltd.)
C3: EBECRYL230 (manufactured by Daicel Ornex) / Urethane acrylate C4: EBECRYL9270 (manufactured by Daicel Ornex) / Urethane acrylate C5: Karenz MTBD1 (manufactured by Showa Denko) / Polymerizable compound having a thiol group C6: Karenz MTPE1 (Showa) Denko Co., Ltd.) / Polymerizable compound having a thiol group C7: KAYAMER PM-21 (manufactured by Nippon Kayaku Co., Ltd.) / Polymerizable compound having a phosphate group
[硬化性組成物の調製]
<比較例1~2、及び実施例6~24>
 下記表1に示す配合割合(質量比)で各成分を混合することで、比較例1~2及び実施例6~24の硬化性組成物(1)~(21)を得た。尚、表1中、数値は硬化性組成物100質量部に対する各化合物の配合割合(質量部)を表す。
[Preparation of curable composition]
<Comparative Examples 1 and 2 and Examples 6 and 24>
By mixing each component in the blending ratio (mass ratio) shown in Table 1 below, curable compositions (1) to (21) of Comparative Examples 1 and 2 and Examples 6 to 24 were obtained. In Table 1, the numerical values represent the mixing ratio (parts by mass) of each compound with respect to 100 parts by mass of the curable composition.
Figure JPOXMLDOC01-appb-T000019
 表1中、「その他」は、特定化合物以外の単官能ラジカル重合性化合物を指す。
Figure JPOXMLDOC01-appb-T000019
In Table 1, "Other" refers to a monofunctional radically polymerizable compound other than the specific compound.
 上記で得られた硬化性組成物を用いて、下記の手法で硬化性組成物の粘度の測定、密着性の評価、及び硬化収縮率の評価を行った。なお、密着性の評価及び硬化収縮率の評価の際には、細孔径1μmのメンブランフィルタで加圧濾過した硬化性組成物を用いた。 Using the curable composition obtained above, the viscosity of the curable composition was measured, the adhesion was evaluated, and the curing shrinkage rate was evaluated by the following method. In the evaluation of the adhesion and the curing shrinkage rate, a curable composition that was pressure-filtered with a membrane filter having a pore diameter of 1 μm was used.
[硬化性組成物の粘度の測定]
 硬化性組成物の粘度は、E型粘度計TVE-25L(東機産業社製)を用い、サンプル量1.1mL、コーンロータTE-1(1°34’、R24)、測定時の回転数10rpm、温度25℃で測定した。
[Measurement of viscosity of curable composition]
For the viscosity of the curable composition, an E-type viscometer TVE-25L (manufactured by Toki Sangyo Co., Ltd.) was used, the sample volume was 1.1 mL, the cone rotor TE-1 (1 ° 34', R24), and the number of rotations at the time of measurement. It was measured at 10 rpm and a temperature of 25 ° C.
[密着性の評価]
<テストセルの作製方法(熱ラジカル開始剤を用いた硬化性組成物)>
 熱ラジカル開始剤を含有する硬化性組成物(1)、(3)~(9)をそれぞれ用いて以下の方法でテストセルを作製した。
 純水、アセトン及びIPA(イソプロピルアルコール)で洗浄したガラス基板(縦:15mm、横:55mm、厚さ:1.1mm)を2枚用意した。上記で得られた硬化性組成物に4μmのビーズスペーサーを0.5質量%添加したうえで、一方のガラス基板(下部ガラス基板1)上にスピンコートし、未硬化状態の硬化性組成物層が形成されたガラス基板(以下、未硬化硬化性組成物層付きガラス基板とも言う。)を得た。その後、図1Aに示すように、もう一方のガラス基板(上部ガラス基板2)を、上記未硬化硬化性組成物層付きガラス基板と直交する向きに中心点が交わるように密着させ、クリップを用いて2枚の基板を圧着させて、圧着セルを得た。上記圧着セルに付着した不要な硬化性組成物を除去した後、熱循環型オーブンに入れ、140℃で1時間加熱処理を行った。処理後、基板を除熱してクリップを外し、密着性評価用のテストセル(熱ラジカル開始剤を用いた硬化性組成物から得られる硬化物を含む)を得た。硬化性組成物にビーズスペーサーを添加したことで、得られたテストセルの下部ガラス基板1と上部ガラス基板2との間には、図1Bに示すように、硬化性組成物から得られる硬化物による接着層領域3が形成されている。
[Evaluation of adhesion]
<Method for producing test cell (curable composition using thermal radical initiator)>
Test cells were prepared by the following methods using the curable compositions (1) and (3) to (9) containing the thermal radical initiator, respectively.
Two glass substrates (length: 15 mm, width: 55 mm, thickness: 1.1 mm) washed with pure water, acetone and IPA (isopropyl alcohol) were prepared. A 4 μm bead spacer was added in an amount of 0.5% by mass to the curable composition obtained above, and then spin-coated on one glass substrate (lower glass substrate 1) to form an uncured curable composition layer. (Hereinafter, also referred to as a glass substrate with an uncured curable composition layer) was obtained. Then, as shown in FIG. 1A, the other glass substrate (upper glass substrate 2) is brought into close contact with the glass substrate with the uncured curable composition layer so that the center points intersect in a direction orthogonal to the above-mentioned uncured curable composition layer, and a clip is used. The two substrates were crimped to obtain a crimp cell. After removing the unnecessary curable composition adhering to the crimping cell, the mixture was placed in a heat circulation type oven and heat-treated at 140 ° C. for 1 hour. After the treatment, the substrate was deheated and the clip was removed to obtain a test cell for adhesion evaluation (including a cured product obtained from a curable composition using a thermal radical initiator). By adding the bead spacer to the curable composition, as shown in FIG. 1B, the cured product obtained from the curable composition is sandwiched between the lower glass substrate 1 and the upper glass substrate 2 of the obtained test cell. The adhesive layer region 3 is formed.
<テストセルの作製方法(光ラジカル開始剤を用いた硬化性組成物)>
 比較例2及び実施例13~22(硬化性組成物(2)、(10)~(19))では、上記と同様の手法で作製した未硬化硬化性組成物層付きガラス基板の塗膜面に、大気下で紫外線発光ダイオードを用いて紫外線を照射した。具体的には、紫外線発光ダイオードの光源の波長が365nmであり、紫外線の照度が6.6mW/cm、照射時間が30秒で行った(合計198mJ/cmの照射量に相当する。)。その後、もう一方のガラス基板(上部ガラス基板2)を、上記紫外線を照射した硬化性組成物層付きガラス基板と直交する向きに中心点が交わるように密着させ、クリップを用いて2枚の基板を圧着させて、圧着セルを得た。上記圧着セルに付着した不要な硬化性組成物を除去した後、熱循環型オーブンに入れ、140℃で1時間加熱処理を行った。処理後、基板を除熱してクリップを外し、密着性評価用テストセル(光ラジカル開始剤を用いた硬化性組成物から得られる硬化物を含む)を得た。
 なお、実施例23及び実施例24(硬化性組成物(20)、(21))では、上記と同様の手法で作製した未硬化硬化性組成物層付きガラス基板を準備し、もう一方のガラス基板(上部ガラス基板2)を、上記未硬化硬化性組成物層付きガラス基板と直交する向きに中心点が交わるように密着させ、クリップを用いて2枚の基板を圧着させて、圧着セルを得た。上記圧着セルに、紫外線発光ダイオードの光源の波長が365nmであり、紫外線の照度が6.6mW/cm、照射時間が220秒の条件で紫外線を照射して(合計1452mJ/cmの照射量に相当する。)、密着性の評価用テストセル(光ラジカル開始剤を用いた硬化性組成物から得られる硬化物を含む)を得た。
<Method for producing test cell (curable composition using photo-radical initiator)>
In Comparative Example 2 and Examples 13 to 22 (curable compositions (2), (10) to (19)), the coating film surface of the glass substrate with the uncured curable composition layer produced by the same method as described above. In the atmosphere, ultraviolet rays were irradiated using an ultraviolet light emitting diode. Specifically, the wavelength of the light source of the ultraviolet light emitting diode was 365 nm, the illuminance of ultraviolet rays was 6.6 mW / cm 2 , and the irradiation time was 30 seconds (corresponding to a total irradiation amount of 198 mJ / cm 2 ). .. After that, the other glass substrate (upper glass substrate 2) is brought into close contact with the glass substrate with the curable composition layer irradiated with ultraviolet rays so that the center points intersect in a direction orthogonal to the above-mentioned ultraviolet rays, and the two substrates are used with clips. Was crimped to obtain a crimp cell. After removing the unnecessary curable composition adhering to the crimping cell, the mixture was placed in a heat circulation type oven and heat-treated at 140 ° C. for 1 hour. After the treatment, the substrate was deheated and the clip was removed to obtain a test cell for adhesion evaluation (including a cured product obtained from a curable composition using a photoradical initiator).
In Examples 23 and 24 (curable compositions (20) and (21)), a glass substrate with an uncured curable composition layer prepared by the same method as described above was prepared, and the other glass was prepared. The substrate (upper glass substrate 2) is brought into close contact with the glass substrate with the uncured curable composition layer so that the center points intersect in an orthogonal direction, and the two substrates are crimped using a clip to form a crimp cell. Obtained. The crimping cell is irradiated with ultraviolet rays under the conditions that the wavelength of the light source of the ultraviolet light emitting diode is 365 nm, the illuminance of the ultraviolet rays is 6.6 mW / cm 2 , and the irradiation time is 220 seconds (total irradiation amount of 1452 mJ / cm 2 ). A test cell for evaluation of adhesion (including a cured product obtained from a curable composition using a photoradical initiator) was obtained.
<密着性の評価方法>
 密着性の評価は、万能試験機EZ-SX100N(島津製作所)と、図2A及び図2Bに示すU字型治具(上部治具4及び下部治具5)を用いて行った。具体的には、試験機の下部治具5に対して、図3に示すテストセルの上部ガラス基板2の下側端部7(下部治具5と接触する領域)が下部治具5の接触部位6(テストセルと接触する部位)と接触するようにセットした。その後、試験機の上部治具4を毎秒5mmの速度で下方に移動させ、上部治具4をテストセルの下部ガラス基板1の上側端部8(上部治具4と接触する領域)に接触させて押し込むことで、2枚の基板から成るテストセルを接着層(硬化性組成物から得られる硬化物)の面から鉛直に剥がした。このときに加えられた力の最大値を接着層領域3の面積で割ることで、密着性を算出した。なお、数値が高いほど、密着性に優れるとした。
<Evaluation method of adhesion>
The adhesion was evaluated using the universal testing machine EZ-SX100N (Shimadzu Corporation) and the U-shaped jigs (upper jig 4 and lower jig 5) shown in FIGS. 2A and 2B. Specifically, the lower end portion 7 (the area in contact with the lower jig 5) of the upper glass substrate 2 of the test cell shown in FIG. 3 is in contact with the lower jig 5 of the testing machine. It was set so as to be in contact with the part 6 (the part in contact with the test cell). After that, the upper jig 4 of the testing machine is moved downward at a speed of 5 mm per second, and the upper jig 4 is brought into contact with the upper end 8 (the region in contact with the upper jig 4) of the lower glass substrate 1 of the test cell. The test cell consisting of two substrates was vertically peeled off from the surface of the adhesive layer (cured product obtained from the curable composition). The adhesion was calculated by dividing the maximum value of the force applied at this time by the area of the adhesive layer region 3. The higher the value, the better the adhesion.
「硬化収縮率の評価」
 硬化収縮率は、硬化性組成物及びその硬化物の密度を用いた密度法で算出した。
 熱ラジカル開始剤を用いた硬化性組成物の硬化物は、窒素雰囲気下、熱循環型オーブンにて、140℃で1時間の加熱処理を行うことで作製した。また、光ラジカル開始剤を用いた硬化性組成物の硬化物は、窒素雰囲気下、光源の波長が365nmの紫外線発光ダイオードを用い、紫外線の照度が6.6mW/cm、照射時間が220秒の紫外線処理(合計1452mJ/cmの照射量に相当する。)を行うことで作製した。
 密度の測定には、乾式密度計アキュピックII(島津製作所)を用いた。
 硬化収縮率は、下記式により算出した。
 硬化収縮率(%)=((d/d)-1)×100
 上記式において、dは硬化前の硬化性組成物の密度、dは硬化後の硬化性組成物の密度である。
 なお、硬化収縮率の数値が低いほど、硬化収縮が小さい、即ち、硬化収縮に優れるとした。
"Evaluation of curing shrinkage rate"
The curing shrinkage was calculated by a density method using the density of the curable composition and the cured product thereof.
The cured product of the curable composition using the thermal radical initiator was prepared by heat-treating at 140 ° C. for 1 hour in a heat circulation type oven under a nitrogen atmosphere. The cured product of the curable composition using the photoradical initiator uses an ultraviolet light emitting diode having a wavelength of a light source of 365 nm under a nitrogen atmosphere, an ultraviolet illuminance of 6.6 mW / cm 2 , and an irradiation time of 220 seconds. It was produced by performing the ultraviolet treatment (corresponding to a total irradiation amount of 1452 mJ / cm 2 ).
A drywall densitometer Accupic II (Shimadzu Corporation) was used to measure the density.
The curing shrinkage rate was calculated by the following formula.
Curing shrinkage rate (%) = ((d 1 / d 0 ) -1) × 100
In the above formula, d 0 is the density of the curable composition before curing, and d 1 is the density of the curable composition after curing.
The lower the value of the curing shrinkage rate, the smaller the curing shrinkage, that is, the better the curing shrinkage.
 熱ラジカル開始剤を用いた硬化性組成物の評価結果を表2に、光ラジカル開始剤を用いた硬化性組成物の評価結果を表3に示す。 Table 2 shows the evaluation results of the curable composition using the thermal radical initiator, and Table 3 shows the evaluation results of the curable composition using the photoradical initiator.
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000021
Figure JPOXMLDOC01-appb-T000021
 表2~表3に示されるように、実施例6~24で得られた特定化合物を含む硬化性組成物は、特定化合物を用いてない比較例の硬化性組成物に比べて、硬化性組成物の粘度が低く、硬化膜を作製した際の密着性が高く、且つ、硬化収縮が小さくなった。具体的には、同一の条件での比較において、比較例1と実施例7との比較、及び比較例2と実施例14との比較である。
 更に、ラジカル重合性化合物に、チオール基を有する化合物を用いた場合、それを用いていない場合に比べて、密着性が高くなった。具体的には、同一の条件での比較において、実施例14と実施例15との比較である。
 加えて、ラジカル重合性化合物に、リン酸基を有する化合物を用いた場合、それを用いていない場合に比べて、密着性が高くなった。具体的には、同一の条件での比較において、実施例17と実施例18との比較である。
 また、ラジカル重合性化合物に、脂肪族ウレタンアクリレートを用いた場合、それを用いていない場合に比べて、硬化収縮が小さくなった。具体的には、同一の条件での比較において、実施例7と実施例8との比較である。さらに、チオール基を有する重合性化合物及びリン酸基を有する重合性化合物を併用した場合、重合性化合物に脂肪族ウレタンアクリレートを用いることで、硬化収縮が小さくなることに加え、密着性も高くなった。具体的には、同一の条件での比較において、実施例18と実施例19との比較である。
As shown in Tables 2 to 3, the curable composition containing the specific compound obtained in Examples 6 to 24 has a curable composition as compared with the curable composition of Comparative Example in which the specific compound is not used. The viscosity of the compound was low, the adhesion when the cured film was produced was high, and the curing shrinkage was small. Specifically, in the comparison under the same conditions, it is a comparison between Comparative Example 1 and Example 7, and a comparison between Comparative Example 2 and Example 14.
Furthermore, when a compound having a thiol group was used as the radically polymerizable compound, the adhesion was higher than when it was not used. Specifically, it is a comparison between Example 14 and Example 15 in the comparison under the same conditions.
In addition, when a compound having a phosphoric acid group was used as the radically polymerizable compound, the adhesion was higher than that when it was not used. Specifically, it is a comparison between Example 17 and Example 18 in the comparison under the same conditions.
Further, when the aliphatic urethane acrylate was used as the radically polymerizable compound, the curing shrinkage was smaller than that when it was not used. Specifically, it is a comparison between Example 7 and Example 8 in the comparison under the same conditions. Furthermore, when a polymerizable compound having a thiol group and a polymerizable compound having a phosphoric acid group are used in combination, by using an aliphatic urethane acrylate as the polymerizable compound, the curing shrinkage is reduced and the adhesion is also improved. rice field. Specifically, it is a comparison between Example 18 and Example 19 in the comparison under the same conditions.
 特定の構造を有する化合物を含む硬化性組成物を用いることで、硬化性組成物の粘度が低く、硬化収縮が小さく、且つ、密着性が高いラジカル硬化型の硬化性組成物が得られる。そのため、本発明の硬化性組成物を接着剤として用いて得られる表示素子や半導体素子は、信頼性に優れたものとなる。 By using a curable composition containing a compound having a specific structure, a radical curable composition having a low viscosity, a small curing shrinkage, and a high adhesion can be obtained. Therefore, the display element and the semiconductor element obtained by using the curable composition of the present invention as an adhesive are excellent in reliability.
 1 下部ガラス基板
 2 上部ガラス基板
 3 接着層領域
 4 上部治具
 5 下部治具
 6 接触部位
 7 下側端部
 8 上側端部

 
1 Lower glass substrate 2 Upper glass substrate 3 Adhesive layer area 4 Upper jig 5 Lower jig 6 Contact part 7 Lower end 8 Upper end

Claims (20)

  1.  下記(A)成分及び(B)成分を含有する硬化性組成物。
     (A)成分:下記式[1]で表される化合物を含む単官能ラジカル重合性化合物
     (B)成分:ラジカル開始剤
    Figure JPOXMLDOC01-appb-C000001
    (式[1]中、Xは下記式[1-a]~式[1-g]から選ばれる構造を示す。
     Xは炭素数2~14の直鎖状のアルキレン基を示す。ただし、前記アルキレン基は、下記(i)及び(ii)の少なくともいずれかの置換が行われていてもよい。
      (i):前記アルキレン基のX又はXと隣り合わない任意の-CH-の、-O-、-CO-、-COO-、-OCO-、-CONH-、-NHCO-、-NH-、ベンゼン環又はシクロヘキサン環への置換
      (ii)前記アルキレン基の任意の-CH-の、-CH(CH)-への置換
     Xは-O-、-CO-、-COO-、-OCO-、-CONH-、-NHCO-又は-NH-を示す。
     Xは炭素数12~40の直鎖又は分岐状のアルキル基を示す。)
    Figure JPOXMLDOC01-appb-C000002
    (Tは水素原子又はベンゼン環を示す。*は結合手を示す。)
    A curable composition containing the following components (A) and (B).
    (A) Component: Monofunctional radically polymerizable compound containing a compound represented by the following formula [1] (B) Component: Radical initiator
    Figure JPOXMLDOC01-appb-C000001
    (In the formula [1], X 1 indicates a structure selected from the following formulas [1-a] to [1-g].
    X 2 represents a linear alkylene group having 2 to 14 carbon atoms. However, the alkylene group may be substituted with at least one of the following (i) and (ii).
    (I): Any -CH 2- , -O-, -CO-, -COO-, -OCO-, -CONH-, -NHCO-,-, which is not adjacent to X 1 or X 3 of the alkylene group. Substitution with NH-, benzene ring or cyclohexane ring (ii) Substitution of any -CH 2- for the above alkylene group with -CH (CH 3 )-X 3 is -O-, -CO-, -COO- , -OCO-, -CONH-, -NHCO- or -NH-.
    X4 represents a linear or branched alkyl group having 12 to 40 carbon atoms. )
    Figure JPOXMLDOC01-appb-C000002
    ( TA indicates a hydrogen atom or a benzene ring. * Indicates a bond.)
  2.  前記式[1]中のXが前記式[1-a]~式[1-d]から選ばれる構造を示し、Xが下記式[X1a]で示される構造であり、Xが-O-、-CO-、-COO-又は-OCO-を示し、Xが炭素数12~40の分岐状のアルキル基を示す請求項1に記載の硬化性組成物。
    Figure JPOXMLDOC01-appb-C000003
    (式[X1a]中、M及びMはそれぞれ独立して、-CH-CH-、-CH(CH)-CH-又は-CH-CH(CH)-を示す。Zは-O-、-CO-、-COO-又は-OCO-を示す。nは0~4の整数を示す。nが2以上の整数の場合、n個のZ及びMはそれぞれ独立して上記定義を有する。*1はXとの結合位置を示し、*2はXとの結合位置を示す。)
    X 1 in the formula [1] indicates a structure selected from the formulas [1-a] to [1-d], X 2 is a structure represented by the following formula [X1a], and X 3 is −. The curable composition according to claim 1, wherein the curable composition represents O-, -CO-, -COO- or -OCO-, and X4 represents a branched alkyl group having 12 to 40 carbon atoms.
    Figure JPOXMLDOC01-appb-C000003
    (In the formula [X1a], M 1 and M 2 independently represent -CH 2 -CH 2- , -CH (CH 3 ) -CH 2- or -CH 2 -CH (CH 3 )-. Z 1 indicates -O-, -CO-, -COO- or -OCO-. N indicates an integer of 0 to 4. When n is an integer of 2 or more, n Z 1 and M 2 are respectively. It has the above definition independently. * 1 indicates the bond position with X 1 and * 2 indicates the bond position with X 3. )
  3.  前記式[1]で表される化合物が、下記式[1a]で表される化合物である、請求項1又は請求項2に記載の硬化性組成物。
    Figure JPOXMLDOC01-appb-C000004
    (式[1a]中、Rは水素原子又はメチル基を示す。L及びLはそれぞれ独立して、-CH-CH-、-CH(CH)-CH-又は-CH-CH(CH)-を示す。Yは-O-、-CO-、-COO-又は-OCO-を示す。nは0~4の整数を示す。nが2以上の整数の場合、n個のY及びLはそれぞれ独立して上記定義を有する。Yは-COO-又は-OCO-を示す。Lは単結合、又は炭素数1~4の直鎖或いは分岐状のアルキレン基を示す。R及びRはそれぞれ独立して炭素数4~18の直鎖或いは分岐状のアルキル基を示す。Rは水素原子、又は炭素数1~18の直鎖或いは分岐状のアルキル基を示す。但し、Lが単結合以外の基を表す場合、L、及びR~Rの炭素数の合計は11~39であり、Lが単結合を表す場合、R~Rの炭素数の合計は11~39である。)
    The curable composition according to claim 1 or 2, wherein the compound represented by the formula [1] is a compound represented by the following formula [1a].
    Figure JPOXMLDOC01-appb-C000004
    (In the formula [1a], R 1 represents a hydrogen atom or a methyl group. L 1 and L 2 are independently -CH 2 -CH 2- , -CH (CH 3 ) -CH 2- or -CH, respectively. 2 -CH (CH 3 )-indicates. Y 1 indicates -O-, -CO-, -COO- or -OCO-. N indicates an integer of 0 to 4. When n is an integer of 2 or more. , N Y 1 and L 2 have the above definitions independently. Y 2 indicates -COO- or -OCO-. L 3 is a single bond or a linear or branched form having 1 to 4 carbon atoms. R 2 and R 3 independently represent a linear or branched alkyl group having 4 to 18 carbon atoms, respectively. R 4 is a hydrogen atom or a linear or branched alkyl group having 1 to 18 carbon atoms. When L 3 represents a group other than a single bond, the total number of carbon atoms of L 3 and R 2 to R 4 is 11 to 39, and L 3 represents a single bond. , The total number of carbon atoms of R2 to R4 is 11 to 39.)
  4.  (C)成分として、2官能以上のラジカル重合性化合物を含有する請求項1~請求項3のいずれか一項に記載の硬化性組成物。 The curable composition according to any one of claims 1 to 3, which contains a bifunctional or higher functional radical polymerizable compound as a component (C).
  5.  前記(C)成分のラジカル重合性化合物が、分子内にチオール基を有する化合物を含む請求項4に記載の硬化性組成物。 The curable composition according to claim 4, wherein the radically polymerizable compound of the component (C) contains a compound having a thiol group in the molecule.
  6.  前記(A)成分がさらに、分子内にチオール基を有する単官能ラジカル重合性化合物を含む請求項1~5のいずれか一項に記載の硬化性組成物。 The curable composition according to any one of claims 1 to 5, wherein the component (A) further contains a monofunctional radically polymerizable compound having a thiol group in the molecule.
  7.  前記(C)成分のラジカル重合性化合物が、分子内にリン酸基を有する化合物を含む請求項4に記載の硬化性組成物。 The curable composition according to claim 4, wherein the radically polymerizable compound of the component (C) contains a compound having a phosphoric acid group in the molecule.
  8.  前記(A)成分がさらに、分子内にリン酸基を有する単官能ラジカル重合性化合物を含む請求項1~7のいずれか一項に記載の硬化性組成物。 The curable composition according to any one of claims 1 to 7, wherein the component (A) further contains a monofunctional radically polymerizable compound having a phosphoric acid group in the molecule.
  9.  前記(A)成分の配合比率が、前記(A)成分及び前記(C)成分の合計100質量部に対して、10~99質量部である請求項4~請求項8のいずれか一項に記載の硬化性組成物。 The item according to any one of claims 4 to 8, wherein the blending ratio of the component (A) is 10 to 99 parts by mass with respect to a total of 100 parts by mass of the component (A) and the component (C). The curable composition according to description.
  10.  前記ラジカル開始剤が、熱でラジカルが発生する熱ラジカル開始剤である請求項1~請求項9のいずれか一項に記載の硬化性組成物。 The curable composition according to any one of claims 1 to 9, wherein the radical initiator is a thermal radical initiator that generates radicals by heat.
  11.  前記ラジカル開始剤が、紫外線でラジカルが発生する光ラジカル開始剤である請求項1~請求項9のいずれか一項に記載の硬化性組成物。 The curable composition according to any one of claims 1 to 9, wherein the radical initiator is a photoradical initiator that generates radicals with ultraviolet rays.
  12.  請求項1~請求項11のいずれか一項に記載の硬化性組成物を用いて得られる光学素子。 An optical element obtained by using the curable composition according to any one of claims 1 to 11.
  13.  請求項1~請求項11のいずれか一項に記載の硬化性組成物を含む接着剤。 An adhesive containing the curable composition according to any one of claims 1 to 11.
  14.  前記接着剤が無溶媒接着剤である、請求項13に記載の接着剤。 The adhesive according to claim 13, wherein the adhesive is a solvent-free adhesive.
  15.  請求項13又は14に記載の接着剤を用いて得られる光学素子。 An optical element obtained by using the adhesive according to claim 13 or 14.
  16.  請求項1~請求項11のいずれか一項に記載の硬化性組成物から得られる硬化物。 A cured product obtained from the curable composition according to any one of claims 1 to 11.
  17.  請求項11に記載の硬化性組成物に紫外線を照射し、その後、加熱処理をして得られる硬化物。 A cured product obtained by irradiating the curable composition according to claim 11 with ultraviolet rays and then heat-treating it.
  18.  下記式[1]で表される化合物。
    Figure JPOXMLDOC01-appb-C000005
    (式[1]中、Xは下記式[1-a]~式[1-g]から選ばれる構造を示す。
     Xは炭素数2~14の直鎖状のアルキレン基を示す。ただし、前記アルキレン基は、下記(i)及び(ii)の少なくともいずれかの置換が行われていてもよい。
      (i):前記アルキレン基のX又はXと隣り合わない任意の-CH-の、-O-、-CO-、-COO-、-OCO-、-CONH-、-NHCO-、-NH-、ベンゼン環又はシクロヘキサン環への置換
      (ii)前記アルキレン基の任意の-CH-の、-CH(CH)-への置換
     Xは-O-、-CO-、-COO-、-OCO-、-CONH-、-NHCO-又は-NH-を示す。
     Xは炭素数12~40の直鎖又は分岐状のアルキル基を示す。)
    Figure JPOXMLDOC01-appb-C000006
    (Tは水素原子又はベンゼン環を示す。*は結合手を示す。)
    A compound represented by the following formula [1].
    Figure JPOXMLDOC01-appb-C000005
    (In the formula [1], X 1 indicates a structure selected from the following formulas [1-a] to [1-g].
    X 2 represents a linear alkylene group having 2 to 14 carbon atoms. However, the alkylene group may be substituted with at least one of the following (i) and (ii).
    (I): Any -CH 2- , -O-, -CO-, -COO-, -OCO-, -CONH-, -NHCO-,-, which is not adjacent to X 1 or X 3 of the alkylene group. Substitution with NH-, benzene ring or cyclohexane ring (ii) Substitution of any -CH 2- for the above alkylene group with -CH (CH 3 )-X 3 is -O-, -CO-, -COO- , -OCO-, -CONH-, -NHCO- or -NH-.
    X4 represents a linear or branched alkyl group having 12 to 40 carbon atoms. )
    Figure JPOXMLDOC01-appb-C000006
    ( TA indicates a hydrogen atom or a benzene ring. * Indicates a bond.)
  19.  前記式[1]において、Xが前記式[1-a]~式[1-d]から選ばれる構造を示し、Xが下記式[X1a]で示される構造を示し、Xが-O-、-CO-、-COO-又は-OCO-であり、Xが炭素数12~40の分岐状のアルキル基を示す、請求項18に記載の化合物。
    Figure JPOXMLDOC01-appb-C000007
    (式[X1a]中、M及びMはそれぞれ独立して、-CH-CH-、-CH(CH)-CH-又は-CH-CH(CH)-を示す。Zは-O-、-CO-、-COO-又は-OCO-を示す。nは0~4の整数を示す。nが2以上の整数の場合、n個のZ及びMはそれぞれ独立して上記定義を有する。*1はXとの結合位置を示し、*2はXとの結合位置を示す。)
    In the formula [1], X 1 indicates a structure selected from the formulas [1-a] to [1-d], X 2 indicates a structure represented by the following formula [X1a], and X 3 is −. The compound according to claim 18, wherein it is O-, -CO-, -COO- or -OCO-, and X4 represents a branched alkyl group having 12 to 40 carbon atoms.
    Figure JPOXMLDOC01-appb-C000007
    (In the formula [X1a], M 1 and M 2 independently represent -CH 2 -CH 2- , -CH (CH 3 ) -CH 2- or -CH 2 -CH (CH 3 )-. Z 1 indicates -O-, -CO-, -COO- or -OCO-. N indicates an integer of 0 to 4. When n is an integer of 2 or more, n Z 1 and M 2 are respectively. It has the above definition independently. * 1 indicates the bond position with X 1 and * 2 indicates the bond position with X 3. )
  20.  前記式[1]で表される化合物が、下記式[1a]で表される化合物である、請求項18又は請求項19に記載の化合物。
    Figure JPOXMLDOC01-appb-C000008
    (式[1a]中、Rは水素原子又はメチル基を示す。L及びLはそれぞれ独立して、-CH-CH-、-CH(CH)-CH-又は-CH-CH(CH)-を示す。Yは-O-、-CO-、-COO-又は-OCO-を示す。nは0~4の整数を示す。nが2以上の整数の場合、n個のY及びLはそれぞれ独立して上記定義を有する。Yは-COO-又は-OCO-を示す。Lは単結合、又は炭素数1~4の直鎖或いは分岐状のアルキレン基を示す。R及びRはそれぞれ独立して炭素数4~18の直鎖或いは分岐状のアルキル基を示す。Rは水素原子、又は炭素数1~18の直鎖或いは分岐状のアルキル基を示す。但し、Lが単結合以外の基を表す場合、L、及びR~Rの炭素数の合計は11~39であり、Lが単結合を表す場合、R~Rの炭素数の合計は11~39である。)

     
    The compound according to claim 18 or 19, wherein the compound represented by the formula [1] is a compound represented by the following formula [1a].
    Figure JPOXMLDOC01-appb-C000008
    (In the formula [1a], R 1 represents a hydrogen atom or a methyl group. L 1 and L 2 are independently -CH 2 -CH 2- , -CH (CH 3 ) -CH 2- or -CH, respectively. 2 -CH (CH 3 )-indicates. Y 1 indicates -O-, -CO-, -COO- or -OCO-. N indicates an integer of 0 to 4. When n is an integer of 2 or more. , N Y 1 and L 2 have the above definitions independently. Y 2 indicates -COO- or -OCO-. L 3 is a single bond or a linear or branched form having 1 to 4 carbon atoms. R 2 and R 3 independently represent a linear or branched alkyl group having 4 to 18 carbon atoms, respectively. R 4 is a hydrogen atom or a linear or branched alkyl group having 1 to 18 carbon atoms. When L 3 represents a group other than a single bond, the total number of carbon atoms of L 3 and R 2 to R 4 is 11 to 39, and L 3 represents a single bond. , The total number of carbon atoms of R2 to R4 is 11 to 39.)

PCT/JP2021/041220 2020-11-11 2021-11-09 Curable composition and cured product thereof WO2022102624A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022561944A JPWO2022102624A1 (en) 2020-11-11 2021-11-09
KR1020237016463A KR20230104893A (en) 2020-11-11 2021-11-09 Curable composition and cured product thereof
CN202180074682.9A CN116391001A (en) 2020-11-11 2021-11-09 Curable composition and cured product thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020188072 2020-11-11
JP2020-188072 2020-11-11

Publications (1)

Publication Number Publication Date
WO2022102624A1 true WO2022102624A1 (en) 2022-05-19

Family

ID=81602312

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/041220 WO2022102624A1 (en) 2020-11-11 2021-11-09 Curable composition and cured product thereof

Country Status (5)

Country Link
JP (1) JPWO2022102624A1 (en)
KR (1) KR20230104893A (en)
CN (1) CN116391001A (en)
TW (1) TW202225354A (en)
WO (1) WO2022102624A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002302687A (en) * 2001-04-06 2002-10-18 Sanyo Chem Ind Ltd Viscosity index improver and lubricating oil composition
JP2003292938A (en) * 2002-03-29 2003-10-15 Sanyo Chem Ind Ltd Viscosity index improver and lubricating oil composition
JP2008183541A (en) * 2007-01-31 2008-08-14 Sanyo Chem Ind Ltd Polymer flocculant
JP2016014826A (en) * 2014-07-03 2016-01-28 三洋化成工業株式会社 Liquid developer
JP2017203835A (en) * 2016-05-10 2017-11-16 日東電工株式会社 Optical film for organic el display devices, polarizing film for organic el display devices, polarizing film with adhesive layer for organic el display devices, and organic el display device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4590732B2 (en) 2000-12-28 2010-12-01 日立化成工業株式会社 Circuit connection material, circuit board manufacturing method using the same, and circuit board
JP5358240B2 (en) 2009-03-25 2013-12-04 積水化学工業株式会社 Adhesive for semiconductor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002302687A (en) * 2001-04-06 2002-10-18 Sanyo Chem Ind Ltd Viscosity index improver and lubricating oil composition
JP2003292938A (en) * 2002-03-29 2003-10-15 Sanyo Chem Ind Ltd Viscosity index improver and lubricating oil composition
JP2008183541A (en) * 2007-01-31 2008-08-14 Sanyo Chem Ind Ltd Polymer flocculant
JP2016014826A (en) * 2014-07-03 2016-01-28 三洋化成工業株式会社 Liquid developer
JP2017203835A (en) * 2016-05-10 2017-11-16 日東電工株式会社 Optical film for organic el display devices, polarizing film for organic el display devices, polarizing film with adhesive layer for organic el display devices, and organic el display device

Also Published As

Publication number Publication date
JPWO2022102624A1 (en) 2022-05-19
CN116391001A (en) 2023-07-04
KR20230104893A (en) 2023-07-11
TW202225354A (en) 2022-07-01

Similar Documents

Publication Publication Date Title
JP5475173B2 (en) Photocurable composition
TWI631168B (en) Solvent-free photocurable resin composition
KR102128799B1 (en) Cured-film-forming resin composition
JP2018104662A (en) Photocurable resin composition and electronic component sealant
KR102341781B1 (en) Resin composition for forming cured film, cured film, electrically conductive member, and method for preventing migration
WO2020196836A1 (en) Pellicle
WO2022102624A1 (en) Curable composition and cured product thereof
TWI777951B (en) Resin composition for high refractive index cured film formation
JP6618186B2 (en) Resin composition and adhesive for electronic parts
JP2018172495A (en) Curable composition, cured product, method for producing cured product, and laminate film and adhesive using the same
JP2013067569A (en) Novel hydrazide compound and resin composition using the same
WO2016084828A1 (en) Resin composition for cured film formation, cured film, electrically conductive member, and corrosion inhibition method for metal electrode and/or metal wiring
JP6204624B2 (en) Thermal radical polymerization initiator using peroxide and thermosetting resin composition
JP2015017060A (en) Peroxide and thermosetting resin composition
WO2018225543A1 (en) Compound and photocurable composition using same
WO2017078087A1 (en) Adhesive composition and structure
CN113260689B (en) Adhesive composition and adhesive tape
WO2016017497A1 (en) Resin composition for forming cured film
TW202411277A (en) Free radical polymerizable compositions and polymers thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21891870

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022561944

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20237016463

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21891870

Country of ref document: EP

Kind code of ref document: A1